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ABSTRACT
PERFORMANCE ANALYSIS OF ORGANIZATIONS
AS COMPLEX SYSTEMS
William C. Harrington, Jr.
April 14, 2017
This dissertation provides a method for evaluating the difference in performance
after an organization makes a change while considering the stochastic nature in which it
operates.

A procedure that uses simulation to estimate outcomes by adjusting

controllable parameters and leaving uncontrolled parameters unadjusted is proposed. As
healthcare organizations are considered as highly complex systems, a case study
involving a scheduling tactic change in the mother-baby service line of a hospital is used
to demonstrate application of this procedure.
The goal in the case study was to reduce delays in transitioning care of mother
patients from the labor and delivery unit to the postpartum care unit. The Holds Rate
metric measured delays as the number of mothers deemed to be unintentionally delayed
from transferring to the postpartum care unit to the total number of deliveries. While the
scheduling tactic change did not yield the anticipated result, the proposed procedure was
used to show that performance would have been worse had the change not been made.
Hospital leadership chose to keep the solution and target performance was later
surpassed. Ultimately, hospital leaders heralded the project as a great success.

v

The proposed procedure was applied with two different simulation methods. A
Monte Carlo simulation model was used to measure Holds Rate and a discrete-event
simulation model to measure the average delay time experienced by patients waiting to
be placed in a postpartum bed following delivery. The results of the procedure with both
models led to the same conclusion that the scheduling tactic change indeed reduced
delays in the transitions of care between the two hospital units.
The case study demonstrated the validity and applicability of the proposed
procedure and organizations may benefit from its use as leaders may be more prone to act
since analysis with the procedure isolates the effects of uncontrolled parameters.
Isolating these effects to better understand those of controlled parameters can promote an
organization’s sustainability by advancing knowledge of cause-and-effect relationships.
Future research with this topic can include application with other simulation methods,
investigating the impacts of technology advancements, and considering a method of
analysis using Bayesian inference.
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CHAPTER 1
INTRODUCTION

1.1 Background
Between 2012 and 2013, I led a project for my employer, Norton Healthcare
(NHC), which involved reducing delays in care transitions for mothers who recently
delivered in the labor and delivery (L&D) unit. The amount of time a patient was
delayed from transferring to the postpartum (PP) care unit was a key factor in
determining a patient to be unintentionally held. This project was relevant to patient
satisfaction, which was measured in the Hospital Consumer Assessment of Healthcare
Providers and Systems (HCAHPS) surveys. Any patient rating for the hospital less than
a 9 on a 0-10 scale is considered unfavorable. An internal study revealed that patients
who were held from the PP care unit were 57% more likely to rate the hospital
unfavorably than other patients. This result was found to be significant by means of a
Two-Proportions Test (p = 0.037).
While improving patient satisfaction was the impetus for the project, there are
other factors apart from considering patients to be held that impact patient satisfaction.
For example, how physicians and staff interact with the patients is one such factor.
Therefore, the scope of the project was to reduce the frequency of patients being held
from the PP care unit as it was not to directly improve patient satisfaction scores.
1

The targeted goal in reducing delays was not initially achieved after implementing
process improvements. However, I suspected that factors outside the control of the
project team contributed to this performance gap. The challenge was how to quantify
what the performance would have been had these conditions been similar to those at the
start of the project. I was familiar with Monte Carlo simulation (MCS) and I had applied
this technique earlier in the project to demonstrate the anticipated impact various
parameter changes would have on delays. I used a less-refined version of the method
discussed in Chapter 3 to demonstrate to hospital leadership that the post-implementation
performance would have been better if conditions outside the control of the project team
had not changed. The analysis allowed leaders to continue their support of the initial
interventions, which eventually led to the goal being exceeded.
This experience inspired me to pursue this dissertation topic as I see opportunity
to use the proposed method to enhance the evaluation of performance in organizations
and thereby promote more appropriate responses in the presence of environmental
variability. I am further hopeful that growth in the availability of electronic data and the
capability of computing will allow the work of this dissertation to be leveraged for
practical use.

1.2 Problem Statement
Organizations are complex systems operating in dynamic environments, often
with limited control. For example, a manufacturer may have minimal influence over the
cost and availability of its resources as well as the price and demand for its end products.
At the same time, the manufacturer could directly change the design of its products,
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production methods, marketing tactics, and other aspects that impact how value is created
and delivered. Therefore, it may be difficult to determine if a change in performance was
due to the actions of leadership or due to market forces beyond the firm’s direct control.
The objective of this dissertation is to provide a method for evaluating the
difference in performance after an organization makes a change while considering the
stochastic nature of the environment in which it operates.

There are two possible

questions that such an organization would want answered:

Question #1: If the post-change approach existed in the baseline, how would the
baseline (pre-change) performance have differed?
Question #2: If the baseline approach still existed, how would the post-change
performance have differed?

While the first question may be limiting since the past cannot be altered, it is still
insightful to know should similar conditions present themselves in the future. The second
question, however, is directly actionable as it addresses the current state conditions.
There are at least two primary benefits for utilizing this type of analysis. The first
benefit is to provide a better gauge of performance shift (i.e., the difference in
performance between two values of interest) between the post-change environment and
the baseline environment to prevent irrational reaction. One such irrational reaction
could be reverting to a prior process even though the new process actually prevented
performance from further deterioration (referred to as the unfortunate loser condition).
Another irrational reaction is applauding a new approach while external forces have been
the primary cause for success and results would have been even better with the prior
method (referred to as the undeserving winner condition).

3

The second benefit is to challenge the extent to which market forces are deemed
uncontrollable. In modeling a real world environment, variables are either deterministic
or stochastic.

With each stochastic variable, there may be parameters that an

organization controls. The sustainability of a firm can be strengthened by identifying
such parameters and leveraging them to mitigate performance headwinds created by the
associated stochastic variables. A key example of this is when a business unit deploys
scheduling tactics to manage demand. While the overall level of demand may not be
directly controlled, although marketing strategies may have some impact, the variation in
daily demand can be regulated.
The hypothesis of this research is that organizations can use simulation to
evaluate the efficacy of a change that has already been made, and that doing so is more
insightful than simply comparing pre-change and post-change performance. To validate
this hypothesis, an actual case study is used.

1.3 Dissertation Organization
After the introduction provided in Chapter 1, a literature review is provided in
Chapter 2. Topics central to this dissertation are discussed, which include understanding
organizations as complex systems and simulation modeling to assess system
performance. Special attention is given to reviewing the presence of complexity and the
use of simulation in healthcare due to the nature of the case study presented. In Chapter
3, the proposed analysis method is detailed. A step-by-step procedure is provided for
answering both questions posed in Section 1.2 above.

Both the validity and the

applicability of this procedure are demonstrated in Chapters 4–6.
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To demonstrate

validity, an actual case study in hospital operations involving a baseline and two
improvement periods is discussed in Chapter 4. To prove the breadth of applicability
with the procedure, analysis was conducted with MCS in Chapter 5 and discrete-event
simulation (DES) in Chapter 6. However, the analysis was restricted in Chapter 6 to only
answering Question #2 for the comparison between the baseline and second improvement
period, and this was due to limitations with the availability of data in the baseline and
first improvement period. Implications of this topic are discussed in Chapter 7. While
the case study illustrates a particular application, the potential for using the proposed
analysis method and subsequent ramifications go well beyond hospital operations and
healthcare.

1.4 Software
Microsoft Excel was used to calculate parameters detailed in Chapter 4 for both
modeling approaches and to create and run the MCS trials in Chapter 5. Microsoft Excel
was also used to calculate values in both Chapters 5 and 6 for Steps 1.7–1.9 and Steps
2.7–2.9 of the proposed procedure outlined in Chapter 3. Minitab was used for all
statistical hypothesis tests (α = 0.05), distribution identification, and regression analyses.
Arena was used to create and run simulations for the DES approach in Chapter 6.
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CHAPTER 2
LITERATURE REVIEW

This chapter provides a summary of the literature review performed. In addition
to the relevant sections of books, papers reviewed include journal articles and conference
proceedings accessed from various search engines and databases including Google
Scholar, Ei Compendex, PubMed, and MEDLINE.

These works cover topics on

organizational science, complex systems, and simulation modeling with application of
these topics in healthcare. Conclusions on current applications of simulation modeling,
especially those pertaining to healthcare, are made in the final section of this chapter.

2.1 Understanding Organizations as Complex Systems
Dooley (2002) found that organizations are viewed as complex systems whose
complexity is a function of its external environment, internal environment, and
institutional environment.

The author defined organizational complexity to be “the

amount of differentiation that exists within different elements constituting the
organization.” An organization’s complexity is driven by various factors including its
structure, authority and locus of control, attributes of personnel, products, and
technologies.

6

Sterman (2001) argued that organizational leaders must be knowledgeable of
dynamic complexity in order to “understand the sources of policy resistance, and design
more effective policies.” Dynamic complexity is the “often counterintuitive behavior of
complex systems” generated by interactions between agents. This is contrasted with
combinatorial complexity, which is the number of components a system possesses or the
number of options to consider in decision making. Also, policy resistance is the tendency
for a system to respond to an intervention in a manner that defeats the aim of the
intervention. The author claimed the heuristics humans use to determine cause-and-effect
relationships “systematically lead to cognitive maps that ignore feedbacks, nonlinearities,
time delays, and other elements of dynamic complexity.” Thus, tools are needed to
understand the workings of dynamic complexity in a system.
Chu et al. (2003) clarified six generators of complexity for any system, which are
internal inhomogeneity, adaptivity, nonlinearity, net-like causality, radical openness, and
contextuality. With radical openness, the interaction between system and ambience is
unbound.

Furthermore, there may be more generators of complexity than the six

discussed.

Therefore, the authors argued that achievement of a unified Theory of

Complexity is unrealistic.
Kinsner (2008) reached a similar conclusion by identifying that the degree of
complexity in a system “appears to be context sensitive, and cannot be defined
universally, once and for all.”

Various contexts for understanding and defining

complexity include the system’s structure, dynamics, function, organizational depth, and
design in its creation. Also, the authors pointed out that the bounds of system stability
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change when a perestroika occurs, which is defined as a “phase transition induced by
changing control parameters or operating conditions of the system.”
Halley and Winkler (2008) postulated the existence of self-organization in a
system is the critical factor in determining emergence to be complex rather than simple,
and a system becomes complex when “complex emergence properties come into being.”
Self-organization is defined as “a dissipative non-equilibrium order at macroscopic
levels, due to collective, nonlinear interactions between multiple microscopic
components.” In other words, a system self-organizes when its agent interactions, which
may vary disproportionately in scale, result in the system dynamically adapting to its
environment. Emergence is “typically described as a property of a system that is not
reducible to, nor readily predictable from the properties of individual system
components” and it ranges on a continuum of simple to complex. To provide examples,
the authors claimed the emergent properties of an ideal gas as “described by a simple gas
law equation” are simple while those of an ecosystem are complex. The authors stated
that “as systems become more complex” they “have multiple hierarchical levels of selforganization.”
Hafez (2010) proposed that the Shannon Communication Model defined in
Shannon and Weaver (1949) can be applied to quantify the system-environment
interaction process. Accordingly, interaction between a system and its environment is
analogous to communication. Under this paradigm, the sensors collecting information
from the environment are synonymous to a communication source, the controller that
determines actions based on the inputs and desired goals functions as a communication
channel, and the effectors implementing the actions are similar to a communication
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destination.

The ability of a complex system to interact with its environment is

dependent on the amount, quality, and relevance of the information it receives, the
availability of dependent responses, and its capacity to process information and determine
responses.
In continuing this work, Hafez (2012) posited that system complexity can be
measured by application of the Shannon Communication Model.

The degree of

complexity present in a system is based on the size of input and output event sets,
considered to be the available communication resources, and the level of dependency
between inputs and outputs, known as I/O dependency. A system is considered to
approach perfect communication efficiency as its I/O dependency makes increasing use
of the available communication resources. However, perfect efficiency is not achieved as
systems continuously become more complex.
Spear (2009) acknowledged that organizations have become more complex as
technological capabilities have advanced over time. The author offered the healthcare
industry as an example where technological growth has resulted in more specialties,
marking an increase in inhomogeneity, which has raised the level of organizational
complexity. Corroboration is provided by Dooley (2002), which stated that “a hospital
would be considered to have quite great complexity,” and Chu et al. (2003), which
indicated that the field of medicine imports “the concepts of and insights from the study
of complex systems.”

9

2.2 Complexity in Healthcare
In 2001, British Medical Journal published a series of four articles on the topic of
complexity science and its relationship to healthcare. Plsek and Greenhalgh (2001)
presented the first article, which showed how a healthcare system can be viewed as a
complex adaptive system (CAS).

The authors defined a CAS as “a collection of

individual agents with freedom to act in ways that are not always totally predictable, and
whose actions are interconnected so that one agent’s actions changes the context for other
agents.” Also, ways in which healthcare systems fit the characteristics of a CAS were
discussed. Two examples are clinical or administrative staff having personal obligations
that may conflict with a change in practice hours, thereby creating fuzzy boundaries of
the system, and care providers having different internal rules for how they choose to
accommodate patient needs. These examples respectively exemplify the concepts of
contextuality and internal inhomogeneity presented by Chu et al. (2003).
In the second article, Wilson and Holt (2001) demonstrated how complexity
science applies to the diagnosis and treatment of patients as well as the promotion of
healthy lifestyles.

Clinical diagnoses are not always certain and there can be

disagreement between clinicians, which are conditions that embody the characteristics of
non-linearity and internal inhomogeneity from Chu et al. (2003). Also, patients have the
autonomy of whether or not to follow a treatment plan, which the authors argued
demands the need for clinicians to understand what attracts patients to healthy or
unhealthy behaviors.

These interactions between patients and clinicians align with

definition of self-organization from Halley and Winkler (2008).
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The third article is that of Plsek and Wilson (2001), who demonstrated how
complexity thinking applies to the organization and management of healthcare systems.
The authors promoted the development of system-level targets and pooled budgets to
encourage the creativity needed to maximize value in care delivery, as opposed to
specifying individual targets and budgets for each agency in the continuum of care. They
proposed that leadership should set a system framework based on minimum
specifications that have directional goals, set boundaries, identified resources, and
established permissions. The authors suggested, “Leadership inspired by complexity
theory recognizes that change occurs naturally within the system and that individuals
engage in this effort for a variety of reasons.” These prescriptions for healthcare system
leadership respect the concepts of adaptivity from Chu et al. (2003) and self-organization
from self-organization from Halley and Winkler (2008).
The four-article series concluded with Fraser and Greenhalgh (2001), who
discussed the need for clinical education to include the development of capability in
addition to competence. Capability entails adapting, learning, and improving, which the
authors argued is essential in healthcare, especially when dealing with atypical patient
presentations.

The authors claimed that an education process providing concurrent

performance feedback enhances capability. They offered an example in the “Norwegian
continuing medical education system, where doctors in a peer group state learning needs,
discuss ways forward, take action, and then report back on the feedback from the action.”
This learning process is described as one where “individuals can achieve more than the
sum of the parts (non-linear effects in a complex system)” and the authors propose that
“both content learning and non-linear learning methods are needed.”

11

Shiell et al. (2008) argued that complex health interventions differ from
interventions made in complex systems, which may require evaluation approaches to
account for the dynamic characteristics of complex systems when they are significant.
Complex interventions, while considered to be complicated by having many components,
do not alone fit the definitions of system complexity. Alternatively, complex systems are
presented as those having properties like interconnectedness and non-linearity.
Interconnectedness can result in spin-off effects and the potential for stakeholders’
concepts of value to change, while non-linearity can be seen in small intermediate
changes being realized before a phase transition occurs. The authors provided evidence
for these concepts in health policy evaluation by citing Siahpush and Scollo (2001),
which documented the increase in support of public smoking bans after policy
implementation. The authors concluded that when the effects of complexity stretch
beyond the capabilities of existing valuation methods, new approaches become necessary.
They proposed such approaches should involve data collection that is inclusive of
potential spin-off effects and modeling techniques that account for non-linear effects and
extended impacts.

2.3 Simulation Modeling to Assess System Performance
Kelton et al. (2015) indicated that simulation “involves systems and models of
them” that are used to mimic real system behavior. Models “serve as a stand-in for
studying” systems. The authors pointed out that systems, including their respective
models, are often studied to measure performance, improve operation, or even evaluate a
potential design.
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Chu et al. (2003) stated a complex system can be modeled provided that (1)
radical openness, or the interactions with an ambient environment, and (2) contextuality,
or the sharing of elements with other systems that take part in other causal processes, are
reducible. Furthermore, it is possible to represent some systems with more than one type
of model.
Casti (1999) documented that a CAS has agents each making decisions based on
deterministic functions of available information, yet the aggregate effect may appear to
be random. A CAS can be modeled at the agent level provided that the following three
conditions are true. First, there are a medium number of agents that is not too large for
intuition and hand-calculation, and is not too small for statistical aggregation to
sufficiently answer the study’s questions. Second, the agents are intelligent and adapt
their behavior by changing their rules, including generating new rules, on the basis of
new information. Third, each agent gets only local information from a relatively small
portion of the other agents and uses this information to reach a decision on the next
action.
Barbati et al. (2012) provided a thorough review to evaluate the impact of agentbased models (ABMs) as they are presented in operational research and management
science literature. Similar to the models discussed in Casti (1999), ABMs “consist of a
set of elements (agents) characterized by some attributes, which interact with each other
through the definition of appropriate rules in a given environment.” The authors argued
that an ABM provides a useful heuristic-based solution approach when the problem is of
large size, has modularity in its domain (i.e., agents make decisions), and when the
domain changes frequently (i.e., agents constantly modify or adapt their decision rules).
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Regarding decision paradigms, an ABM consists of either a cooperative or a competitive
paradigm. Cooperation-based interaction entails use of planning approaches to manage
resource constraints so global goals are achieved, while competition-based interaction
entails negotiation among self-interested agents, thereby hindering the opportunity for
global optimization.

Common uses of ABMs for optimization include scheduling,

transportation / logistics, and supply chain planning.
In the event that statistical aggregation can sufficiently answer the study’s
questions, it is possible to use modeling approaches other than an ABM. Kelton et al.
(2015) provided three dimensions to classify a simulation model. First, the model can be
static or dynamic, where dynamic models are time dependent as they have trials whose
results are a function of previous trials, while the trials of static models are independent
from each other. Second, the elements of the model can be either continuous or discrete,
where continuous elements are not bound by events that can only occur at separated
points in time as is the case for discrete elements. Models can be purely continuous,
purely discrete, or mixed. Third, the model can be either deterministic or stochastic,
where a deterministic model does not have any random inputs like those present in a
stochastic model. When statistical aggregation is suitable, stochastic models can be
applied. In particular, the authors presented DES as a dynamic and discrete stochastic
modeling approach that is useful for understanding business operations.
Anderson et al. (2006) acknowledged that MCS is historically understood to be a
static simulation approach while many individuals today take the term to mean any form
of a stochastic simulation. The authors presented a hypothetical example of modeling the
operation of a computer manufacturer using the historical approach for MCS. In the
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example, direct labor cost, parts cost, and first-year demand were all randomly generated
to compute profits in a stochastic model that was static and continuous. While the
example could have also been modeled using DES (e.g., order intake fluctuation
requiring inventory, part expedites, and overtime costs), it demonstrated the ability to
also use MCS for this type of problem.
Another modeling approach is system dynamic (SD) simulation. Sterman (2001)
stated that SD modeling and simulation are tools to “design and evaluate new policies
before implementing them in the real world.” SD models account for the elements of
dynamic complexity by incorporating feedback loops and stock and flow structures,
which can both be shown on causal loop diagrams (CLDs). Feedback loops can be
positive (i.e., self-reinforcing) and “amplify whatever is happening in the system” or they
can be negative (i.e., self-correcting) and oppose changes in the system.

A set of

interacting model equations is derived from a CLD, with probability factors included for
elements that have uncertainty and may dynamically change. The model equations can
then be used in dynamic simulation to show time delays and nonlinear behavior of the
system.
Halley and Winkler (2008) clarified that modeling a relationship at a system level
with state variables (e.g., MCS and SD models) may be just as effective at predicting
system behavior as a component-level model with individual events (e.g., ABMs and
DES models). When a system-level model is reasonably as effective at prediction as a
component-level model, the state variables of the system-level model are identified as
“real emergent properties.” The authors pointed out that the PV = nRT relationship of
modeling the thermodynamic properties associated with a gas is at the system-level and,
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while possible, component-level models that make the same predictions based on
molecular dynamics would add negligible value to the analysis of gases in closed vessels.
Mustafee et al. (2010) included an overview of when each of these four
simulation techniques is typically applied. DES was found to be popular for modeling
queuing systems. MCS is typically applied when computation of an exact value for a
response variable is “impossible or infeasible” using fixed values of input variables or by
using deterministic algorithms. SD is used to analyze the “behavior of complex systems
over time” with the core assumption that changing one part of a system “will impact all
other parts of an interrelated system.” Finally, agent-based simulation (ABS) is wellsuited for modeling when assumptions at an agent interaction level do not infer obvious
results at a system level.

2.4 Simulation Modeling in Healthcare: An Overview
There exists a multitude of examples where simulation has been applied to better
understand healthcare, which affirms the previous comments on complexity in this field.
Five literature review articles are discussed in this section. The following three sections
(i.e., 2.5–2.7) contain a sample of articles from journals and conference proceedings that
cover a diverse range of topics pertaining to simulation in healthcare. These papers are
directly associated with the operations of healthcare facilities or supporting tools such as
clinical science and economic evaluation, which may impact the decisions made within
healthcare operations.

Also, Section 2.8 discusses barriers to implementing

recommendations from simulation models in healthcare given that such implementation
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is rarely documented, which is a topic discussed in four of the five literature review
articles in this section.
Jun et al. (1999) provided a literature review focused primarily on works
published between the mid-1970’s and 1997 of simulation applied to the operational
needs of health care clinics. Topics addressed included patient flow, resource allocation,
and other future opportunities for improvement. The authors found patient flow is
addressed through scheduling and patient routing, and resource allocation has covered
sizing and planning of beds, rooms, and staff. While the authors identified that use of
DES in healthcare grew over the time period reviewed, there was little evidence of
recommendations

from

simulations

being

successfully implemented.

Future

opportunities presented by the authors included complex multi-facility studies, leveraging
optimization techniques with simulation, more user-friendly simulation software, and
addressing implementation issues. Finally, an observation of this journal article is that it
is referenced by all four of the other literature review articles showcased.
Fone et al. (2003) reviewed 182 papers published between 1980 and 1999
covering topics relating to computer simulation of stochastic systems with individuals in
a population health or health service delivery setting. The authors used an appraisal
method adopted from a prior published format that first screened each paper, then
assessed its validity, and finally evaluated its overall results and findings. Papers were
categorized into five topic groups. Articles related to hospital scheduling were found to
be the most prevalent, but tend to be of poorer quality as compared to those for screening
patients. A key deficit of hospital scheduling articles is that “very few papers reported
that models had been implemented.” In fact, the authors were “unable to reach any
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conclusion on the value of modeling in health care because the evidence of
implementation was so scant.” However, an increasing trend in the “numbers of quality
papers published in medical or health services research journals” was found. Regarding
simulation methodology, the authors reveal that DES was the most commonly used
modeling approach, while MCS prevails in cancer screening studies.
Brailsford et al. (2009) searched roughly 10,000 articles and methodically
identified 342 articles for full review that pertain to simulation and modeling in
healthcare contexts. These articles were published between 1952 and 2007 and are
categorized by nine different attributes with subsequent analysis. This effort supported a
broader aim of developing a user guide to suggest appropriate modeling methods relative
to problem type in healthcare.

While forms of modeling beyond simulation were

considered, simulation was noted as “dominant in planning and system / resource
utilization.” Despite a growing trend with almost 50% of all modeling articles and over
60% of simulation articles published between 2000 and 2007, fewer than 10% of studies
had their findings implemented regardless of modeling method. However, a significant
number of studies’ findings have been discussed with client organizations. Furthermore,
the authors found evidence of unpublished modeling work in healthcare performed by
business consultants and employed analysts based on commercial and promotional
literature. Regarding funding of published studies, academia was the dominant source
under any modeling method while commercial funding sources were primarily restricted
to simulation studies.
Mustafee et al. (2010) queried papers published between 1970 and 2007 listed in
the ISI Web of Science® database with simulation in the healthcare context. After initial
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screening, 201 papers published between 1988 and 2007 were reviewed for
categorization by simulation technique and topic, profiling of key attributes (e.g., authors,
publication year, etc.), and strategic importance of papers and authors.

Strategic

importance was determined via a five-stage co-citation analysis. The authors found MCS
to be the most commonly used simulation method followed by DES, SD, and ABS.
Regarding applications, MCS was mainly used for health economics and evaluation of
health interventions, DES was often applied for problems concerned with patient flow
and resource scarcity, and SD was used for broad scale modeling of health systems and
policy. The authors could not comment on the application trends for ABS as only two of
the papers used this method, which were both published in 2006. The use of simulation
in healthcare was observed as a growing trend due to the steady increase in publications
between 2000 and 2007. Regarding key significant publications, the authors identified
five turning point articles, three of which are included in this Chapter 2 with Jun et al.
(1999) being one and the other two being discussed in the following pages.
Günal and Pidd (2010) provided a review of articles published between 1965 and
2009 that discussed DES modeling in healthcare with a focus on patient flows through
hospitals and their departments. Articles were classified by hospital area of application
and accident and emergency (A&E) units were the most popular application for DES,
with a variety of modeling objectives mentioned. Inpatient units and outpatient clinics
were other popular areas for modeling. Inpatient models tended to focus on “patient
flows to hospital beds, bed occupancy, and length of stay (LOS)” while outpatient models
were mostly concerned with scheduling and capacity planning. Despite other areas like
operating rooms and critical care units having been modeled, there were very few
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examples of whole hospital DES models and most studies were unit specific, which the
authors found to potentially neglect interactions with other units. The authors also
identified long project cycle times, project cost, and determining the appropriate model
accuracy as factors that continue to serve as “barriers to the successful implementation of
simulation.” While generic modeling software exists, the vast majority of articles focus
on models developed for very specific applications, and the authors conclude this lack of
genericity has resulted in case studies that seldom lead to common insights or general
theory.

2.5 Simulation Modeling in Healthcare: DES Models for Operations
This section provides an assortment of papers demonstrating the use of DES to
model healthcare operations. Applications have included a variety of surgical, inpatient,
and ambulatory care environments. Five papers discuss models developed and a sixth
article relates to the use of modeling software designed for the healthcare industry.
The earliest healthcare operations simulation paper reviewed is Schmitz and
Kwak (1972). The authors used DES to determine how many new operating rooms (OR)
and recovery rooms (RR) were needed to accommodate an expected increase in surgical
volume. Also, a method was detailed for forecasting the volume increase, which was
based on a 144 bed expansion of the medical-surgical (M/S) unit. The forecast assumed
that expansion of the M/S unit would result in full bed utilization and that increased
surgical demand would have the same case mix as the prior year. Simulation was then
used to determine the number of OR’s and RR’s needed such that delays would not occur
once surgery began. The only stochastic variable in the model was the type of surgery
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performed, which was determined based upon generating a single random exponential
number (REN) from a single uniform random number (URN) for each event. Surgical
duration, whether or not a RR is used, and time spent in the RR were all based on the
REN and were unique values for each surgical case type. Other variables like transfer
time from an OR to an RR, and make-ready times for OR’s and RR’s are all constant
values regardless of case type. Additional daily surgical volumes were fixed at 27 cases
per day, “which was the predicted new surgical load due to the increased bed
compliment.” Despite the limited amount of simulated values, the authors claimed that
the method applied was “extremely accurate” once actual observation of the constructed
department was possible.
Dexter et al. (1999) discussed use of DES to derive an OR scheduling strategy
that maximizes OR utilization. Simulating OR suites allowed the research team to gather
a substantial amount of data and generate statistically meaningful findings, as decades or
more of real world samples would have been required due to the presence of autocorrelation in successive OR utilization measurements. The model included five input
parameters that required 216 combinations of discrete values to determine significant
factors, and the average delay in patients being scheduled for surgery was found to have
the greatest impact on OR utilization in an inverse relationship.

Eleven questions

addressing the concerns of key stakeholders (i.e., patients, surgeons, anesthesiologists,
OR managers, etc.) were formulated to evaluate alternative strategies for managing
varying objectives that may have conflicted with one another. For example, a key
concern for patients was extensive delays to having surgery, while OR utilization was a
substantial concern for hospital leaders due to high staffing costs that were relatively
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fixed. The authors proposed a three-part scheduling strategy that first allocated block
times (i.e., specified time windows for surgery) to surgeons based on the expected time
needed for elective cases. Second, patients were scheduled into the first available open
block provided it fell within four weeks of the request. Third, patients who were not
assigned to an open block within four weeks of the request were then scheduled in an
overflow time outside of a block. The proposed strategy involved shifting the locus of
control for scheduling “from the surgeon and patient to the OR suite,” which presented a
barrier to implementation.
Swisher and Jacobson (2002) shared a DES model developed to recommend
operational parameter settings for a two-physician family practice healthcare clinic based
on the results of simulation optimization to maximize clinic effectiveness (CE). CE is a
multi-attribute variable “constructed on a monetary scale” that considers clinic profit,
patient satisfaction, and staff satisfaction. A two-physician clinic was selected for the
study “due to their prevalence, especially among those clinics that do not have an existing
network or hospital affiliation.” A fractional factorial experimental design was applied to
identify four significant parameters out of the six considered. Afterward, the authors
applied a two-stage optimization technique in the model, which first eliminated any
statistically non-optimal solutions and then presented optimal solution alternatives that
maximized CE for further evaluation. Clinical decision-maker(s) were involved in the
study presented, but there was no evidence presented of the model being used to make
operational decisions.
Ahmed and Alkhamis (2009) proposed a method using system simulation
combined with optimization to maximize throughput in an emergency department (ED)
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by considering different staffing distributions across functional roles (e.g., doctors,
nurses, etc.). A DES model was nested in the optimization model to quantify average
throughput and delays. The optimization model used a two-phase approach where Phase
I identified feasible and near-feasible solution alternatives to be evaluated in Phase II,
which identified the optimal solution from the alternatives. The optimization model had
a mix of stochastic and deterministic functions between the objective and constraints with
patient arrival rates and process service times as the stochastic variables. Despite the
model finding an optimal solution that improved service performance while not
exceeding current costs, hospital management had concerns over the impact to staffing
distribution efficiency and overall individual waiting time. Unfortunately, there was no
evidence of any recommendations being implemented.
The final paper reviewed that documents a healthcare operations study using DES
is Thorwarth et al. (2009), which showed how DES was used to validate an analytical
model for assessing utilization in the flexible workload environment of an ED. The
workload was flexible since nurses managed a variety of separate tasks for a several
patients during the same timeframe. The analytical model could be used to predict
utilization based on patient interarrival time, service time, the number of staff, and the
number of tasks, where utilization was the product of activity utilization and staff
utilization. The results of the analytical model were compared to those of the simulation
model and differences were “ultimately due to the variability caused by random arrival
rates.” The authors determined that system instability, which was represented in high
utilization and ever growing wait times, occurred when the longest service rate was
greater than the arrival rate and when the number of staff was less than the number of
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tasks. While there was no evidence that the model had been used by operational decision
makers, the authors proposed that it could have been used to vary staffing levels such that
utilization would not exceed 85% as studies were cited to show the costs of excessively
high utilization. These costs included occupational burnout, absenteeism, higher error
rates, and increased patient mortality risk.

The model was limited due to its

simplification of only considering nursing staff and that it did not account for service rate
variation, however the authors contended that decision makers could “still use the model
to achieve a greater transparency” of conditions critical to system operation.
Regarding software for modeling operations with DES, Harrell and Lange (2001)
showcased MedModel, a simulation software specifically designed for healthcare
operations. The authors argued that specialized simulation software was necessary for
the healthcare industry due to its unique issues. Process flows in healthcare operations
were described as complex due to variable pathways, multiple tasks that may be repeated,
and other forms of operational variety.

For example, the software employs patient

identity numbers to match split entities (e.g., when a lab is processed while a patient
flows to radiology for a test). MedModel also allows for a number of queue management
rules and representative logic allows for resources to be preempted, given that both of
these functions are important in healthcare as priorities are often based on patient acuity.
Program logic also supports resources being used for a wide variety of tasks or situations,
flexible shift patterns, and both bidirectional and unidirectional pathways.

Finally,

MedModel was designed so model code could be programmed in a menu-driven logic
builder with a user-friendly interface.

Despite such efforts to make the software
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functional and user-centered in its design, the authors did not provide any real world
applications of the software.

2.6 Simulation Modeling in Healthcare: Other Models for Operations
This section reviews papers on the use of simulation methods for modeling
healthcare operations other than DES alone. These include MCS and SD modeling,
which can also be used in conjunction with DES.

Two papers covered modeling

applications and another two discussed modeling approaches.
Harrison et al. (2005) shared the development of a simulation model to calculate
bed occupancy of a hospital’s medical division while accounting for variability in
admissions and transitions of care between three stages that may all exist in the same
unit. In their review, Günal and Pidd (2010) classified this model as a “Monte Carlo
model rather than a DES model,” while detailed inspection revealed that the model was
dynamic and system state variables were simulated rather than event-level variables. The
authors found that the model had at least five areas of application for hospital
administrators. The areas of application included identifying abnormal bed demand
levels and contributing factors, determining target occupancy rates, assessing the impact
of growth or expansion, understanding the impact of short-term vs. long-term occupancy,
and evaluating tactics to smooth variability. Regarding its breadth of application, the
model was formulated in a way that produced generic equations for any hospital to use,
thereby contributing knowledge that is broadly applicable in healthcare. Regarding the
model’s validity, admission and transition parameters for stochastic input variables were
derived and validated using actual hospital data along with the final model output
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showing “no statistically significant difference” when compared to actual occupancy
data. The authors concluded that understanding the “variability in the number of beds
occupied is essential to improving the management and increasing the efficiency of
hospitals” and that “smoothing out the variation in discharge rates may be more effective
than smoothing the variations in admission” based on the various model results.
However, no evidence of the model being used or key findings being implemented was
provided.
Brailsford et al. (2004) discussed the creation of an SD model consisting of both
qualitative and quantitative phases to simulate the flow of admissions to hospital wards
from various pathways and identify bottlenecks in the broader healthcare system of
Nottingham, England. SD modeling was applied due to the size of the system being
modeled and computational efficiency concerns associated with large scale DES models,
whereas a DES model was used to investigate patient routing options within the A&E
unit. The SD model was validated by having the key stakeholders of the project’s
Steering Group be engaged with its qualitative structure and by having its quantitative
output for bed occupancies compared to actual data that was not part of the model’s
construction. Data in the model consisted of patient encounter information and arrival
rates through two sources channeled to seven sectors before inpatient admission, however
the “quality and level of data were variable.” Stakeholders benefited from the qualitative
phase by gaining a complete view of the system and gathering insights on system
interactions impacting their respective components. The quantitative phase yielded value
by demonstrating the impacts and effectiveness of different interventions aimed at
improving flows by reducing emergency admissions and the Steering Group was “keen to
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suggest alternative scenarios for testing.” The study had been conducted jointly “with a
health and social care community” that valued the system-level approach to development.
The authors claimed that both the “process and findings of this independent inquiry”
appeared to have favorably impacted local efforts to solve emergency care access
problems.
Regarding the use of SD, Taylor and Lane (1998) contrasted the value of SD
simulation to understanding and solving problems in healthcare with that of traditional
simulation approaches. A detailed comparison between SD and DES is provided to
highlight these differences.

While the authors acknowledged that the stages of

developing an SD model are similar in their respective scopes and challenges as other
modeling approaches, SD models provide some advantages.

Specifically, SD adds

unique value in its ability to model both the physical and information delays associated
with dynamic complexity and to capture organizational complexity “through the explicit
representation of intangibles and the distinction between perceived and actual values.”
However, the authors stated that SD is limited in considering detailed complexities,
whereas “DES primarily concentrates on detail complexity.” A hypothetical example of
addressing waiting times for coronary heart disease (CHD) treatment was provided where
both DES and SD are used for different purposes. The DES model focused on changes to
treatment strategies and localized decisions to impact queues within hospital, while the
SD model was concerned with the “feedback processes underlying changes to waiting”
including treatment effectiveness.

The authors concluded that “no single modeling

approach can offer a panacea to management problems” and “it is important to
acknowledge the limitations of a method and to understand its scope.”
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Regarding the use of SD and DES together, Chahal and Eldabi (2008) argued that
both detailed operations and environmental interactions need to be understood to make
effective and sustainable decisions in healthcare systems, which were viewed as complex
and adaptive. The authors proposed using a hybrid approach that applies both discreteevent simulation (DES) and system dynamics (SD) for each mode of governance
presented. In a top-down mode where leadership at the strategic level set targets and
passes them down to operational management, a hierarchical method can be used. This
starts with strategic level decisions represented in an SD model that are then passed to a
DES model to validate operational feasibility via a cycle of output from one model being
used as input to another. In a network partnership mode where pathways for patient care
span a network of independent service providers, a process–environment method can be
used. This functions similar to the hierarchical method, but starts with process changes
being represented in a DES model. Finally, in a quasi-market mode where strategic
leadership and operational providers are bound by contracts, an integrated method can be
used with elements represented in either model. Similar to Taylor and Lane (1998), the
authors found that DES is effective for modeling detailed operations, while SD is
effective for capturing dynamic complexities from interaction between system
components, so the two modeling methods can complement each other.

2.7 Simulation Modeling in Healthcare: Models beyond Operations
In this section, seven papers are reviewed that discussed modeling a variety of
topics in the fields of clinical science, health economics, and healthcare accreditation.
These papers provide examples of DES, MCS, and SD models. Three papers that used
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DES are presented first, followed by two papers that used MCS and then another two
papers that used SD modeling.
Barth-Jones et al. (2000) demonstrated the use of DES to validate that
retrospective partner trial (RPT) study designs are accurate and have significant statistical
power in estimating human immunodeficiency virus (HIV) vaccine effectiveness
parameters provided sufficiently large sample sizes are used. Standard vaccine trial
design is only capable of detecting Vaccine Effects on Susceptibility (VES), where
susceptibility is the risk of becoming infected. However, RPT and DES designs can
additionally evaluate Vaccine Effects on Infectiousness (VEI), where infectiousness is the
ability of an infected individual to transmit the disease to other individuals. Both VES
and VEI are important for reducing transmissibility and the study showed a >90% chance
that an RPT design would have found a vaccine that reduces transmissibility by 81.25%
to be efficacious. However, a standard vaccine trial design would have a ~50% chance of
rejecting the same vaccine due to its low VES value. DES was used to find that HIV
infection risk varies among individuals due to epidemic transmission dynamics as it
provides perfect information with all events being known. RPT study design, however,
has incomplete information as partners may not be remembered or may not be contacted.
Despite this concern with RPT design, the authors found that it has sufficient statistical
power when partner data is randomly missing based on comparisons with DES study
results.
Cooper et al. (2002) detailed the development of a model depicting the treatment
and subsequent disease states and interventions for coronary heart disease (CHD) patients
who have had a coronary event. The model used DES to simulate the next event type
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(i.e., disease state or intervention) and time following the current event. Past surveys and
studies were used to define model data used for time-to-event parameters and event type
probabilities with assumptions and extrapolations having been made when desired
prognostic factors were not “broken down sufficiently.” The main difficulties the authors
encountered in gathering model data were discrepancies between studies using different
approaches to acquire data, patient and other factor or result categories being excluded
from studies, complete absence of desired data, and diagnostic coding errors or
limitations jeopardizing the quality of data.

Patient Oriented Simulation Technique

(POST) software, which allows for more than one future event to be prescribed to patient
entities with the possibility of events taking place in parallel, was used to write
simulation code. The simulation showed a 50% increase in angiogram referrals and
doubling bypass grafts and angioplasties had negligible effect on rates for myocardial
infarctions and CHD-related deaths. The authors planned to continue model development
through refinement of the parameters and they concluded that initial results pointed to
higher volumes of revascularizations having minimal impact on myocardial infarction
and death rates.
Babad and Sanderson (2002) is the second turning point article from Mustafee et
al. (2010) featured in this chapter. In their work, the authors described the process of
developing the primary prevention strategy component of a model for assessing the
economic impacts of various Coronary Heart Disease (CHD) management approaches.
The model, which was still under development during publication, used DES to simulate
the time between events that trigger “changes in risk factors and/or changes in disease
status” for “individual members of populations” serving as model entities. The model
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data used to define time-to-event parameters were based on past surveys and studies.
While some desired data elements were not available, the authors planned to include such
data in future versions of the model. Other parameters defining probabilities of patient
behavior in response to prescribed treatment and treatment effectiveness were based on
estimates gathered from literature review. Regarding model setup, it was designed for
users to specify or confirm parameters prior to running the model, which allowed for
various intervention strategies to be evaluated. To run the model, simulation routines
established “specifically for modelling healthcare systems” were applied and flags were
set when non-fatal disease events occur, which triggered the treatment model component
described in Cooper et al. (2002).

Regarding validation, the authors mentioned a

forthcoming paper that would provide details on testing for technical accuracy and
consistencies in the model pertaining to “the feasible range of parameter values” and the
“model’s results with observed data.”
Zenios et al. (1999) investigated alternative methods for allocating cadaveric
kidneys with the aim of identifying the method that best balances efficient allocation and
equitable allocation, especially in terms of racial equity. Four alternatives were evaluated
against two efficiency measures, which were patient survival and quality-adjusted life
expectancy, and two equity measures, which were waiting time and likelihood of
transplantation. The current allocation strategy at the time, which was the point system
used by the United Network of Organ Sharing (UNOS), was considered along with three
other allocation methods. These were a first-come first-transplant (FCFT) system, an
efficiency-based algorithm, and a distributive efficiency algorithm, which mimicked the
efficiency-based algorithm except that race was not considered in prioritization. The
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authors described using an MCS model to simulate the “operations of a single organ
procurement organization” and generate results from a 10-year simulation run length,
which was found to be sufficient from the sensitivity analysis performed. The model
contained five internal models, which simulated arrival rates for candidates and donors,
patient outcomes while waiting for transplantation and following such treatment, and the
decision-making for organ allocation. Data for model parameters were gathered from
UNOS and United States Renal Data System (USRDS) reports and sensitivity analysis of
model parameters did not change qualitative findings.

The distributive efficiency

algorithm was found to provide the greatest benefits overall without penalizing AfricanAmericans. Thus, the authors concluded the development of “evidence-based policies
that simultaneously improve health outcomes for all patients with end-stage renal
disease” is possible.
Kahn et al. (2007) described how cohort data from a clinical database was used in
an MCS study to analyze changes in the Standardized Mortality Ratio (SMR) from
increasing the out-of-hospital transfer rate. SMR compares the hospital’s mortality rate
to an expected value based on severity of illness and case mix with any value over one
indicating an elevated mortality rate. The study was performed using a final cohort of 85
Intensive Care Units (ICUs) and the data gathered contain seven discharge locations,
including dead, with two being considered as transfers to other care centers. The MCS
model applied an algorithm that adds a uniformly distributed random number to each
patient’s scaled risk of hospital death score in order to identify upper percentile patients
for transfer. Simulations were performed at transfer increases of 2% and 6% above
baseline, where all patients who were not originally transferred but selected by the
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algorithm were recoded as a living transfer discharge, including those who were
originally coded as dead. Subsequently, “SMR was recalculated” along with transfer
bias, which is defined as “the difference between the mean simulated SMR and the
original SMR.”

The study found that increasing out-of-hospital transfers causes “a

significant downward bias in the SMR at both 2% and 6% above baseline” and an ICU
could significantly improve its SMR rank. The authors argued in their conclusion that
the “transfer bias presents an important limitation to the SMR” and “uncritical use of the
SMR to benchmark ICU performance is likely to misinform rather than provide
meaningful information about ICU quality.”
Banz et al. (2003) discussed a study to evaluate three vaccination strategies for
varicella (or chickenpox) in Germany against the current strategy at the time, which only
administered vaccines to high risk groups and was also known as a “no vaccination”
strategy. The study used a model, referred to as economic varicella vaccination tool for
analysis (EVITA), to assess the economic impacts of each vaccination strategy from both
societal and payer perspectives. While not explicitly identified as such, EVITA could be
classified as an SD model based on its structure and operation. The authors described
EVITA as being an “age-structured deterministic model based on a set of differential
equations” where “probabilities at each chance node determine the flow of patients
through the simulation tool.” In the model, the population was “divided into 1-year age
cohorts” from age 0 to 70 and a time-step dt of one year was used for a simulation length
of 30 years. Probabilities of infection, or annual attack rates, were set for five age
categories and probabilities were also set for other factors including vaccination
coverage, vaccine efficacy, and clinical outcomes. In addition to a base case, best and
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worst case scenarios were developed by simultaneously varying parameters that had
“considerable uncertainty and high sensitivity” with vaccination coverage and various
costs. The various cost discount rates were identified as having the highest sensitivity.
The key finding of the study was that a strategy to vaccinate children between 12 and 18
months of age or another strategy that also vaccinates adolescents between 11 and 12
years of age are both substantially more effective that the current strategy or one that only
vaccinates adolescents. However, this finding assumed vaccination coverage rates of
75% or more and the authors also concluded coverage rates below 50% could cause the
average age of infection to increase, which results in worse outcomes and higher costs.
The third and final turning point article from Mustafee et al. (2010) presented in
this chapter is Hammerschmidt et al. (2003). In the paper, the authors presented the
efforts to validate the EVITA model proposed in Banz et al. (2003) as “the acceptance of
models is highly dependent on their validity.” Five validation methods were discussed
and the authors were able to apply four of the five methods, which the authors used to
collectively validate the model. EVITA was said to meet descriptive validity as Module
1, which was “an age-structured, deterministic model” leading up to the point of
infection, was “based on an established and peer-reviewed model.” Module 2 of EVITA,
which “describes the course of varicella and its potential complications as well as the
associated health-care resource utilization,” was found to meet descriptive validity. The
authors held this claim since the “data and development” were “reviewed by a German
expert panel and deemed to provide an adequate picture of the course of varicella and its
clinical management in Germany.” Technical validity was proven by applying extreme
values to generate outcomes that would have been expected and face validity was shown
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as the model produced a result similar to that of prior literature for vaccination coverage
levels required to eliminate varicella when the same assumptions were made.
Convergent validity was demonstrated by “comparing the results of other models with the
result of the EVITA model” and finding similar results when accounting for parameter
differences. However, the authors could not assess predictive validity since “no data are
available on the effects of universal varicella vaccination in Germany.”

2.8 Simulation Modeling in Healthcare: Barriers to Implementation
As previously mentioned, four of the five literature review articles presented in
Section 2.5 indicated that recommendations from simulation models in healthcare are
rarely documented as being implemented. The next three papers have discussed barriers
to such implementation.
Sanchez et al. (2000) provided a compilation of submitted statements from the
authors for a panel discussion at the 2000 Winter Simulation Conference. The intent of
the discussion was to identify key issues that need to be addressed for simulation to be
effective in healthcare, and the authors represented the healthcare industry, consulting,
and academia. Many of statements made were shared amongst the authors and they
acknowledged that simulation can help healthcare leaders understand processes so that
realistic financial performance targets can be set with operational plans to achieve them.
However, healthcare models often have conflicting objectives when “the opinions of
hospital managers clash with those of medical personnel.” Other barriers to effective
modeling include lack of available data and the extensive time often required to observe
healthcare processes in developing a representative model. Data availability and integrity
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is of critical concern as “small variations in some distribution parameters, or (worse) a
change in the distribution itself, usually leads to significant changes in model results” and
possibly different conclusions. The authors recommended that both operational and
clinical leadership be engaged in projects for these barriers to be addressed and for key
model recommendations to be supported for implementation.
Eldabi and Paul (2001) argued that traditional simulation modeling approaches do
not focus on problem formulation and structuring, which are key to understanding
problems, and that problem definition is paramount to modeling healthcare problems.
The authors proposed a modeling approach that demands iterative communication
between various stakeholders and the model itself during model development, which
helps to ensure that objectives and constraints are properly expressed. The approach is
referred to as a Modeling Approach that is Participatory Iterative for Understanding
(MAPIU) and it consists of an initialization stage and a processing stage. Initialization
classifies stakeholders as problem owners, experts, and actual users in order to “ease the
process of collecting the right information based on the needs of the problem owners for
a given problem.” The processing stage entails modeling, communication, and deriving
information, which are parallel components that evolve during the modeling process. An
example of using MAPIU to model the decision making process for liver transplant
allocation is provided with stakeholders being health economists, who are classified as
problem owners and actual users, and clinicians, as experts. These stakeholders have
differing views regarding the method for liver allocation, which drives iteration through
the processing stage components to reach a final model. The authors concluded that
MAPIU features of stakeholder participation and iterative processing aim to address the
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challenges associated with “lack of understanding of the healthcare process by the
concerned people,” conflicting objectives, and intercommunication difficulties.
Brailsford (2005) discussed the obstacles to successfully implementing
recommendations from simulation models in healthcare environments and offered insight
to why these obstacles exist.

The author presented an example of a successful

implementation effort, which addressed meeting demand for emergency care in
Nottingham, England as documented in Brailsford et al. (2004), which was reviewed in
Section 2.6. Factors for success with the example are identified as “impetus for the
project” coming from the client, a “charismatic and enthusiastic local sponsor” chairing a
Steering Group that was involved in model development, a multi-disciplinary research
team, and a high priority on data collection.

Regarding barriers to implementing

recommendations from any project, the author defined such challenges pertaining to
culture, cost, data, incentives, and the level of specificity required. Recommendations
were made for academia and practitioners, modeling software developers, and healthcare
providers. Academia and practitioners were advised to address problems critical to
hospitals and patients, identify “enthusiastic and powerful” project sponsors, create multidisciplinary teams, and balance “user-friendliness with scientific rigor and validity” in
models.

Developing models that can be easily tailored for various hospitals by

identifying the “basic components of all patient flow systems” was an additional
challenge that was also extended to software developers and MedModel is cited as such
an attempt, which was presented in Section 2.5 with Harrell and Lange (2001). Finally,
the author encouraged healthcare providers to pool resources with partners and work
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together, overcome “cultural issues and resistance to change,” and implement “robust,
practical data collection systems.”

2.9 Observations of Existing Literature
The literature shared in this chapter has put forth a number of concepts relevant to
this dissertation.

First, organizations can be viewed as complex systems and their

complexities can be defined in a myriad of contexts. Also, healthcare organizations are
recognized as having great complexity.
Regarding simulation, a system can be modeled as long as its complexity is
reducible, and there are multiple approaches to system modeling and simulation. The
literature focuses on models used to evaluate potential system designs and how
performance would differ from the current state. There does not appear to be use of
simulation to evaluate current or past performance or the effectiveness of a new system
design that is already implemented. In healthcare, such use is even less likely due to the
lack of implementation associated with simulation study recommendations. In fact, in
gathering papers for the literature review, a search in Google Scholar used the phrases
“simulation performance analysis organizations” and “model performance analysis
organizations” to see if any papers address the two questions posed in Chapter 1. Google
Scholar was used due to the breadth of its search capabilities, but none of the papers
sampled had titles or abstracts covering this interest.
Regarding performance analysis, current health economic valuation approaches
do not utilize modeling techniques that account for non-linear effects and extended
impacts from interconnected system components. Therefore, problems may exist in some
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models that prevent them from being used for assessing effectiveness of changes made.
Also, metrics may be chosen as performance indicators without consideration of all the
influencing factors, and this may be especially true for healthcare quality measures.
Given that healthcare organizations are identified as being highly complex and that their
performance metrics may have many influencing factors, a case study in healthcare
operations seems appropriate in validating an approach to answering the two questions
posed in Chapter 1. Chapter 3 presents the methodology proposed to answer these two
questions.

39

CHAPTER 3
METHODOLOGY

The proposed method seeks to answer the two questions posed in Chapter 1 using
simulation.

These questions, which are restated below, are graphically depicted in

Figures 1 and 2.

Question #1: If the post-change approach existed in the baseline, how would the
baseline (pre-change) performance have differed?
Question #2: If the baseline approach still existed, how would the post-change
performance have differed?

The solid line in Figure 1 shows the actual performance between time T0 and T1,
while the dashed line indicates performance between T0 and T1 if the post change
approach were in place during T0. The estimated value for Y0′ is better than Y0, which
indicates that performance would have been improved in T0 had the change been in place.
Conversely, in Figure 2, the dashed line demonstrates performance between T0 and T1 if
the change had not been in place during T1, while the solid line is the same as that of
Figure 1. Y1 is better than the estimated value for Y1′, which indicates that performance
in T1 would have been worse had the change not been in place. While this example
shows that actual performance has benefited from the change, this will not always be the
case.
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Y0' Comparison to Y0
Performance Metric Value (Positive Direction is Favorable)

25

20

15
Y0 to Y1
Y0' to Y1

10

5

0
0

1
Time Period

Figure 1: Graphical depiction of answer to Question #1

Y1 Comparison to Y1'
Performance Metric Value (Positive Direction is Favorable)

14
12
10
8
Y0 to Y1

6

Y0 to Y1'

4
2
0
0

1
Time Period

Figure 2: Graphical depiction of answer to Question #2
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In order to answer these questions, a procedure is developed as the central focus
of this research. This procedure involves using a modeling approach that applies factor
values that are derived from statistical aggregation in simulations to develop statistical
distributions of comparison values that are then analyzed. This procedure first begins
with an analysis of the baseline as described in Step 0.1 below:
Step 0.1 Identify a representative model linking the performance metric (response
variable) to the input variables (factors), of which at least one needs to be
stochastic in nature.
Question #1 above can be answered with the approach outlined as follows:
Step 1.1 Use simulation to develop a distribution of the response variable based on
the model.
Step 1.1.1

Identify distributions of factors in the baseline data.

Step 1.1.2
Use simulation to develop a distribution of the response using the
model from Step 0.1 and the factor distributions from Step 1.1.1.
Step 1.2 Determine the probability of the baseline performance observation along
with the cumulative distribution function (CDF) for the distribution found in Step
1.1.2. Record this as the baseline CDF probability.
Step 1.3 If necessary, repeat Step 0.1 to identify any new relationship between the
response and the factors following the change made. If the model from Step 0.1
is still valid, continue using that model.
Step 1.4 Use simulation to develop a distribution of the response using the model
from Step 1.3 and factor values from Step 1.4.1 and Step 1.4.2. Record these as
T0′ factor values.
Step 1.4.1
For factors that have been influenced by the change, identify the
new values or distributions from the post-change data. Apply these to the
simulation as this is necessary to reflect the new method.
Step 1.4.2
For factors that have not been influence by the change, leave
values or distributions as they were in the baseline.
Step 1.5 Determine the simulated baseline value (Y0′) based on the baseline CDF
probability from Step 1.2 and the distribution found in Step 1.4.
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Step 1.6 Compare the simulated baseline (Y0′) from Step 1.5 to the actual baseline
performance observed (Y0). Express the performance shift (Δ0′/0) in % Y0′
improved over Y0 performance terms based on the desired direction of Δ0′/0 as
defined in Equation (1).
(
{
(

⁄

Step 1.7

)⁄
)⁄

(1)

Repeat Steps 1.1–1.6 to develop a distribution of comparison values.

Step 1.8 If a targeted performance shift was set, determine the probability of the
targeted performance shift along with the CDF for the distribution found in Step
1.7. Record this as the baseline performance shift CDF probability. If a targeted
performance shift was not established, review the distribution of comparison
values from Step 1.7 and analyze the results.
Step 1.9 Estimate the probability that the targeted performance shift would have
been achieved in the baseline by subtracting the baseline performance shift CDF
probability from one.
A process flow diagram of the procedure to answer Question #1 is shown in Figure 3.
Review distribution of
performance shift values
(Step 1.8)

Identify a model
for baseline relationship
(Step 0.1)

No

Develop distribution
from model with
baseline (T0) data
(Step 1.1)

No

Determine baseline
CDF probability
(Step 1.2)

Evidence that the
relationship between factors and
response has changed?
(Step 1.3)

Desired number
of trials completed?
(Step 1.7)

Compare Y0' to Y0 to
estimate
performance shift
(Step 1.6)

No

Yes

Targeted
performance shift
set?
(Step 1.8)

Determine Y0' based on the
baseline CDF probability
from Step 1.2 and the
distribution from Step 1.4
(Step 1.5)

Yes

Determine baseline
performance shift
CDF probability
(Step 1.8)

Estimate the probability that the
targeted performance shift would
have been achieved in the baseline
(Step 1.9)

Develop distribution
from model with T0'
factor values
(Step 1.4)

Use model identified
in Step 0.1
(Step 1.3)

Yes
Identify a model for
the post-change
relationship
(Step 1.3)

Figure 3: Process flow diagram of the procedure to answer Question #1
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Question #2 above can be answered with the approach outlined as follows:
Step 2.1 If necessary, repeat Step 0.1 to identify any new relationship between the
response and the factors following the change made. If the model from Step 0.1
is still valid, continue using that model.
Step 2.2

Repeat Step 1.1 with the post-change data.

Step 2.2.1

Identify distributions of factors in the post-change data.

Step 2.2.2
Use simulation to develop a distribution of the response variable
using the model from Step 2.1 and the factor distributions from Step 2.2.1.
Step 2.3 Determine the probability of the post-change performance observation
along with the CDF for the distribution found in Step 2.2.2. Record this as the
post-change CDF probability.
Step 2.4 Use simulation to develop a distribution of the response using the model
from Step 0.1 and factor values from Step 2.4.1 and Step 2.4.2. Record these as
T1′ factor values.
Step 2.4.1
For factors that have been influenced by the change, leave values
or distributions as they were in the baseline.
Step 2.4.2
For factors that have not been influenced by the change, identify
the new values or distributions from the post-change data. Apply these to
the simulation as this is necessary to reflect the post-change environment.
Step 2.5 Determine the simulated post-change value (Y1′) based on the post-change
CDF probability from Step 2.3 and the distribution found in Step 2.4.
Step 2.6 Compare the actual post-change performance observed (Y1) to the
simulated post-change (Y1′) from Step 2.5. Express the performance shift (Δ1/1′)
in % Y1 improved over Y1′ terms based on the desired direction of Δ1/1′ as defined
in Equation (2).
⁄

Step 2.7
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{
(

)⁄
)⁄
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Repeat Steps 2.1–2.6 to develop a distribution of comparison values.

Step 2.8 If a targeted performance shift was set, determine the probability of the
targeted performance shift along with the CDF for the distribution found in Step
2.7. Record this as the post-change performance shift CDF probability. If a
targeted performance shift was not established, review the distribution of
comparison values from Step 2.7 and analyze the results.
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Step 2.9 Estimate the probability that the targeted performance shift would have
been achieved in the post-change environment by subtracting the post-change
performance shift CDF probability from one.
A process flow diagram of the procedure to answer Question #2 is shown in Figure 4.
Identify a model
for baseline relationship
(Step 0.1)

Evidence that the
relationship between factors and
response has changed?
(Step 2.1)

Yes

No
No

Identify a model for
the post-change
relationship
(Step 2.1)

Use model identified
in Step 0.1
(Step 2.1)

Compare Y1 to Y1' to
estimate
performance shift
(Step 2.6)

Desired number
of trials completed?
(Step 2.7)

Estimate the probability that the
targeted performance shift would
have been achieved post-change
(Step 2.9)

Yes
Develop distribution
from model with
post-change (T1) data
(Step 2.2)

Determine Y1' based on the
post-change CDF probability
from Step 2.3 and the
distribution from Step 2.4
(Step 2.5)

Determine
post-change CDF
probability
(Step 2.3)

Develop distribution from model
with T1' factor values using
model identified in Step 0.1
(Step 2.4)

Targeted
performance shift
set?
(Step 2.8)

Yes

Determine post-change
performance shift CDF
probability
(Step 2.8)

No
Review distribution of
performance shift values
(Step 2.8)

Figure 4: Process flow diagram of the procedure to answer Question #2

The application of this procedure is demonstrated in Chapters 5 and 6. Detailed
explanation of each procedural step is provided in these chapters to illustrate the
underlying logic of the procedure. However, the following paragraphs include some
general comments on the procedure.
Selecting the modeling approach is paramount in Step 0.1. As Kelton et al.
(2015) stated, the type of model chosen will depend on how the system can be described.
As shown in the case study presented and analyzed in Chapters 4–6, there may be more
than one way to describe, and thereby model, the system.
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The possibility of needing to develop a new model is raised in Steps 1.3 and 2.1.
Such a need depends on the modeling approach and the changes made. In a regressionbased model, factor values beyond the range observed in the baseline would require new
model formulation according to the assumptions associated with the use of regression
models as stated by Montgomery (2013). Regarding a DES model, a structural change in
the system would require a new model to be developed. For example, if two process
steps are coupled into one step, then a queue is eliminated.
The term CDF probability is used in several of the procedure’s steps. As Devore
(1995) indicated, CDF probability is the location of a particular value in the outcome
distribution, a figure that is measured from zero to one. The CDF probability can also be
thought of as the chance that the particular value of interest is greater than a randomly
selected value in the outcome distribution.
In Step 1.2, the baseline CDF probability is calculated using the distribution of
possible performance values given the distributions of the inputs during T0 and the actual
performance metric value of T0 (Y0). The baseline CDF probability is used in Step 1.5 to
estimate the value of the performance metric in T0 if the input parameters affected by the
change were in place during T0 while considering the same CDF probability associated
with Y0. This metric is referred to as Y0′ and the altered state of T0 is referred to as T0′.
In Step 2.3, the post-change CDF probability is calculated using the distribution
of possible performance values given the distributions of the inputs during T1 and the
actual performance metric value of T1 (Y1). The post-change CDF probability is used in
Step 2.5 to estimate the value of the performance metric in T1 if the input parameters
affected by the change were not in place during T1 while considering the same CDF
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probability associated with Y1. This metric is referred to as Y1′ and the altered state of T1
is referred to as T1′.
In Step 1.8, the baseline performance shift CDF probability is calculated using the
distribution of comparison values found in Step 1.7 and the targeted performance shift
value if one was established. A targeted performance shift is defined as the minimal
amount of improvement required in the performance metric value for the change
implemented to be considered a success. In Step 1.9, the baseline performance shift CDF
probability is subtracted from one to estimate the probability that the targeted
performance shift would have been achieved in the baseline.
In Step 2.8, the post-change performance shift CDF probability is calculated using
the distribution of comparison values found in Step 2.7 and the targeted performance shift
value if one was established.

In Step 2.9, the post-change performance shift CDF

probability is subtracted from one to estimate the probability that the targeted
performance shift would have been achieved in the post-change environment.
Chapter 4 details the case study that Chapters 5 and 6 both use to demonstrate the
analysis procedure outlined in this Chapter 3. Chapters 5 and 6 also reveal that this
procedure can be applied using different simulation methods to model the same
environment and reach similar conclusions.
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CHAPTER 4
CASE STUDY:
MOTHER-BABY THROUGHPUT IMPROVEMENT PROJECT

The case study presented involves an improvement project in the mother-baby
service line at then-named Norton Suburban Hospital (NSH) in Louisville, KY. The
project’s key metric was the Holds Rate, which is defined as the ratio of mothers
considered to be unintentionally delayed (i.e., held) from transferring to the postpartum
(PP) care unit to the total number of deliveries (i.e., births). The project goal was to
reduce the Holds Rate by 15% as holding patients was correlated to lower satisfaction
scores. Figure 5 shows the typical patient flow from delivery to discharge.
Typical Patient Flow from Delivery in L&D to Discharge from PP

L&D

Nursing Unit
Delivery
(time of last baby if
multiples)

Immediate
Post-Delivery Care
(weigh baby, cut umbilical cord,
placental expulsion, etc.)

Wait for PP
Room Ready

Transfer to PP Room

PP

Postpartum Care
(mother’s recovery, vaccinations, circumcision as requested,
hearing screen, coaching on breast feeding, governmental
documentation, car seat test, etc.)

Figure 5: Typical patient flow from delivery in L&D to discharge from PP
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Discharge

The mother-baby service line is itself an organization within the hospital. There
are many different agents including administrators, nurses, obstetricians, pediatricians,
anesthesiologists, and environmental services staff all working together to serve the
mother and infant patients and their families.

The mother-baby service line has

properties matching the six generators of complexity identified by Chu et al. (2003) as
shown in Table 1.
Table 1: Chu et al. (2003) Complexity Generators Mapped to Mother-Baby Service Line Properties

Complexity Generator
Internal inhomogeneity
Adaptivity
Nonlinearity

Net-like causality

Radical openness

Contextuality

Property of a Mother-Baby Service Line
Different classes of autonomous agents are present (e.g.,
obstetricians, pediatricians, L&D nurses, PP nurses, staff,
leadership, etc.).
Agents of the care delivery system can adapt to dynamics
(e.g., physicians protect interests of only their patients).
Interactions of scheduling with Holds Rate are nonlinear as
utilization has a nonlinear impact on queue time.
When a delivered mother is held from a PP unit, the PP care is
delivered in another place that is not designed for PP care.
This is not ideal for patient care and other risks may
propagate.
Changes in system can impact other business decisions or
patient preferences, but this is reducible as a relatively stable
environment existed in the time periods observed.
Obstetricians and pediatricians working have office practice
hours away from the hospital, but this is reducible as the LOS
in PP (PP LOS) is fairly predictable.

Another aspect that illustrates the complexity present in the mother-baby service
line is the presence of self-organization as defined by Halley and Winkler (2008). This
can be evidenced by interactions between physicians and patients being nonlinear due to
emotions, which can be overwhelming in nature.

For example, there may be

disagreement between an obstetrician and the laboring patient on when cesarean delivery
is needed during a prolonged attempt at vaginal delivery.
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Data was collected and analyzed over four separate time periods, as defined in
Table 2. The time periods are not adjacent and the specific reasons supporting this
approach are discussed in the following paragraphs.
Table 2: Time Period Definitions

Name
Regression Study
(RS)
Baseline (BL)

Duration
115 consecutive days
between 1Q 2012 and 2Q
2012
63 consecutive days between
1Q 2012 and 2Q 2012

Improvement Period 1 63 consecutive days between
(IP1)
4Q 2012 and 1Q 2013
Improvement Period 2 63 consecutive days between
(IP2)
2Q 2013 and 3Q 2013

Considerations
None
A portion of the regression study
selected to be same length as IP2
L&D scheduling tactic change
was implemented and selected to
be same length as IP2
New EHR implementation
complete and ends with start of
construction work

The first time period, Regression Study (RS), was a period of time longer than the
others as this data was used to establish the regression equation to estimate daily Holds
Rate values in the MCS model. Routine data collection mostly consisted of counting the
daily numbers of deliveries and holds. All other data collection for the project was ad
hoc and sometimes cumbersome. The project team used the data for RS to develop a
causal model to predict Holds Rate via regression as understanding cause and effect was
the focus of project work during the early phases of the project.
Baseline (BL) is a portion of RS that was selected to be the same length as
Improvement Period 2 (IP2), which was nine full weeks (i.e., Sunday through Saturday).
Improvement Period 1 (IP1) was also the same length as IP2, as keeping all time periods
used in the comparative analysis the same length reduced the impact of sample size on
standard deviation, and this was a key parameter in the analysis. Devore (1995) detailed
the relationship between sample size and standard deviation.
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IP1 began with the implementation of a scheduling tactic change in L&D, which
is viewed as a perestroika event and ended with the implementation of a new electronic
health record (EHR) system. Implementing the new EHR system was disruptive and it
took users some time to adjust. Also, data was not captured for time stamps needed to
determine PP LOS in IP1. This was due to the difficulty of retrieving the time stamp data
and administrative resources were preoccupied with preparation for conversion to the
new EHR system. PP LOS and all related metrics for IP1 are estimated for purposes of
the analyses in Chapter 5.
IP2 began following a period for users to adjust to the new EHR system and
ended with the start of a new construction project, which temporarily reduced the number
of rooms for PP. IP2 also included the on-boarding of a new PP nurse manager who,
with the assistance of her staff, refined the checklist used to coordinate events leading up
to patient discharge.

While nurses routinely used the checklist to more effectively

manage shift hand-off communication, this checklist did not impact PP LOS or its
variation.
A major benefit with the new EHR system used in IP2 was the enhanced reporting
capabilities. The new system not only made it possible to capture PP LOS for IP2, but
also enabled the team to study the time it takes to clean and prepare a PP room for the
next patient following a discharge.

Another advantage was that the delay between

delivery and transfer to the PP room could be calculated.
In IP1, the project goal of reducing the Holds Rate by 15% was not achieved
while the goal was exceeded in IP2. Chapter 5 details how the procedure was applied to
assess Holds Rate performance by answering Questions #1 and #2 for both improvement
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periods using an MCS model. Regression was used to develop the simulation equation
for MCS. This approach was necessary due to the judgment involved in determining the
hold status of a patient, which is discussed below and is viewed as difficult to define
entirely by a deterministic algorithm.
Chapter 6 shows how the procedure was used with a DES model to assess transfer
delay performance by answering Question #2 for IP2 since this was the only comparison
with sufficient data to support the analysis. Since the system involved a queue between
L&D and PP, DES was applied as a simulation technique to validate that the scheduling
tactic change indeed reduced delays in the care transitions.
The two modeling approaches, MCS and DES, were applied to demonstrate the
generality of the procedure. The observations from Mustafee et al. (2010) on MCS and
DES applications support both approaches as being acceptable simulation techniques.
Dependent variables for the MCS model were the number of holds (Holds) and
Holds Rate. Holds were tabulated on a daily basis as the number of patients considered
to be held from the PP care unit based on a nurse’s judgment, which included assessing
factors related to clinical care and patient-family satisfaction. For instance, a study IP2
data revealed that 21.5% of patients who waited over three hours to be transferred to a PP
room were logged as a hold, which implies factors other than queue time influenced this
judgment. However, delay in transferring the patient still had a substantial influence on
nurses’ judgment as only 1.7% of patients who waited three hours or less for transfer to
the PP room were logged as a hold.
Holds Rate is defined as the ratio of Holds to Daily Deliveries, with Daily
Deliveries being the number of newborns delivered in a day. The regression model,
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which was a component of the MCS model, was used to directly calculate Holds Rate and
then Holds was calculated by multiplying Holds Rate by Daily Deliveries. Holds Rate
was also calculated over a 63 day simulation run length and the 63 Day Holds Rate was
the output of each simulation run.
The DES model was used to calculate the time each patient spent waiting to be
transferred to her bed in the PP care unit following delivery (Delay Time). Delay Times
were averaged over a 63 day simulation replication length following a 7-day warm-up
period and the 63 Day Average Delay Time (ADT) was the output of each replication.
Several key independent variables were considered in each model.

For the

regression model, Daily Deliveries and the PP LOS associated with the PP discharges for
each day (Days D-C PP LOS) are considered. These variables were also measured over a
two-day interval. For the DES model, independent variables existed at a more granular
level than the regression model and were used to describe patient deliveries, patient stays,
or the hospital. Patient delivery variables included the Hourly Rate of Deliveries (HRD),
Delivery Type (i.e., vaginal or cesarean), and whether a delivery was Single Birth or
Lastborn Twin as all multiple deliveries were twins in IP2.

Patient stay variables

included time required to care for a mother immediately after delivery (L&D PostDelivery Care Time), the time to transport a patient from L&D to PP (Patient Transport
Time), and time for a PP room to be cleaned following the stay (D-C to Room Clean
Time). The Number of PP Rooms was the only hospital variable and it reflected the
hospital’s ability to accommodate patient care in the PP care unit. Table 3 summarizes
the key variables considered in each model.
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Table 3: Listing of Key Variables (2 Days are day and prior day)

Variable Name
(regression code)
Holds Rate
Holds
Delay Time
Daily Deliveries (A)
Days D-C PP LOS (B)
2 Days Deliveries (C)
2 Days D-C PP LOS (D)
Hourly Rate of Deliveries
Delivery Type
Single Birth or Lastborn Twin
L&D Post-Delivery Care Time
PP LOS
Patient Transport Time
D-C to Room Clean Time
Number of PP Rooms

Variable Type

Model(s)

Dependent
Dependent
Dependent
Independent / Stochastic
Independent / Stochastic
Independent / Stochastic
Independent / Stochastic
Independent / Stochastic
Independent / Stochastic
Independent / Stochastic
Independent / Stochastic
Independent / Stochastic
Independent / Stochastic
Independent / Stochastic
Independent / Deterministic

MCS Model
MCS Model
DES Model
Regression (for MCS)
Regression (for MCS)
Regression (for MCS)
Regression (for MCS)
DES Model
DES Model
DES Model
DES Model
DES Model
DES Model
DES Model
DES Model

Table 4 provides data by time period for the regression model. Analysis to
develop the model revealed that the interaction term of Days D-C PP LOS (B) and 2
Days Deliveries (C), or C*B, was the only significant term. Chapter 5 provides a detailed
discussion of the regression analysis completed for Step 0.1.
Table 4: Summary of Data Provided for Regression Model Used for the MCS Model
Time Period Total No.
(days)
of Holds

Total No. Overall
of
Holds
Deliveries
Rate

Daily
Deliveries
μ /σ

Distribution
of Daily
Deliveries

Daily
Discharges
μ /σ

Distribution of
Daily Discharges

Daily Average
PP LOS (days)
μ /σ

RS
(115)

88

1560

5.64%

13.57 / 4.84

Normal
p = 0.127

BL
(63)

46

849

5.42%

13.48 / 5.17

Normal
p = 0.173

Normal
13.78 / 4.89
Transformed
3.65 / 0.67 (Box-Cox λ = 0.5)
p = 0.289

2.54 / 0.24
0.93 / 0.10

IP1
(63)

45

851

5.29%

13.51 / 4.94

Normal
p = 0.346

Normal
13.29 / 4.27
Transformed
3.57 / 0.60 (Box-Cox λ = 0.5)
p = 0.504

IP2
(63)

28

854

3.28%

13.56 / 4.74

Normal
p = 0.050

Normal
13.52 / 4.25
Transformed
3.63 / 0.59 (Box-Cox λ = 0.5)
p = 0.593

Distribution of Daily Days D-C
Daily Average
PP LOS
PP LOS
μ /σ

34.58 / 11.99

Normal
p = 0.388

Normal
Transformed
(Box-Cox λ = 0)
p = 0.794

34.90 / 12.28

Normal
p = 0.612

2.53 / 0.27
0.92 / 0.11

Normal
Transformed
(Box-Cox λ = 0)
p = 0.896

33.16 / 11.15

Normal
p = 0.392

2.56 / 0.27
0.93 / 0.10

Normal
Transformed
(Box-Cox λ = 0)
p = 0.158

34.61 / 11.22

Normal
p = 0.127

Not used in regression analysis

α = 0.05
Values after transformation (distributions selected to be most appropriate fit over all 3 time periods for comparative analysis)
Per Two-Sample t Test, Daily Avg PP LOS for BL and IP2 found to be same
Note: Shaded area contains simulated data for IP1, which was generated using data from BL and IP2
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Distribution
of Daily Days
D-C PP LOS

As indicated in Table 4, data was not captured for Daily Average PP LOS during
IP1. However, data for this figure was captured in both BL and IP2. Furthermore, Daily
Average PP LOS was tested for stability between these time periods. Figure 6 shows the
spread of the normal transformed data (Box-Cox λ = 0), and this type of distribution is
also known as a lognormal distribution. In Figure 6, the vertical lines represent the first
and fourth quartiles, the shaded rectangles represent the second and third quartiles, and
asterisks signify outlier data points.
Boxplot of LN(Daily Avg PP LOS): BL vs. IP2
1.2

LN( Daily Avg PP LOS)

1.1
1.0
0.9
0.8
0.7
0.6
BL

IP2

Figure 6: Boxplot with Two-Sample t Test for Daily Average PP LOS (LN = Box-Cox  = 0)

A Two Sample t-Test was used to compare the mean value of the normal
transformed data for BL to that of IP2. Also, equal variances were assumed as an F-Test
showed no significant difference (p = 0.666). The Two-Sample t-Test found that the BL
mean did not significantly differ from the IP2 mean (p = 0.747), so stability between the
time periods was demonstrated with these results. Therefore, IP1 is assumed to have the
same distribution as the other two time periods, which was normal transformed (Box-Cox
λ = 0) with transformed mean of 0.93 and standard deviation of 0.10.
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Daily Average PP LOS data was simulated for IP1 in order to include it in the
analysis. Values for the natural log of Daily Average PP LOS were randomly generated
using the mean and standard deviation parameters, 0.93 and 0.10, respectively, for a
lognormal distribution. The simulated data had a mean of 0.92 and standard deviation of
0.11. Daily Average PP LOS values were attained by converting each simulated value,
and this permitted Daily Days D-C PP LOS (measured in patient days) to be assessed.
In the DES model, each newborn baby enters the system as an entity upon
delivery. If the baby is from a single birth or if the baby is the lastborn of a multiple
birth, then the entity converts to a mother and enters the queue for being transferred to a
PP room. Based on the delivery type and weekday of delivery, the mother’s PP LOS is
determined and she exits the system upon discharge.

However, the PP room is

technically occupied until it is clean and available for the next patient. Therefore, the
DES model has a single resource type, the PP room, which is seized by the entity, the
patient encounter, until the PP room is clean.
While other factors could have been incorporated in the DES model, they are not
necessary due to statistical aggregation.

For instance, human resources like nurses,

physicians, and room cleaning staff are not included. This is due to the fact that the
distributions of PP LOS and D-C to Room Clean Time inherently account for the
availability of these resources. Chapter 6 provides a detailed discussion of the DES
model developed for Step 0.1.
Table 5 provides data by time period for the DES model. As shown, data is not
provided for IP1. This is due to the absence of delivery time stamp data needed for
calculating the HRD values required by the DES model. Also, data was not available for
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other elements of the DES model in BL due to the limitations of the EHR used during
that time period. Table 5 indicates the data not available for BL in the sections shaded in
gray. As a result, analysis with the DES model was limited to Question #2 for the IP2 vs.
BL comparison.
Table 5: Summary of Data Provided for the DES Model
Avg.
Delivery
Time
Delay Hourly Rate Type Prob.:
Period
Time of Deliveries Vaginal /
(days)
(hours)
Cesarean

Prob. of
Single Born
or Lastborn
Twin (ψ )

Varies by day Varies by day
and shift
and shift
(See Table 6) (See Table 7)

BL
(63)

IP2
(63)

Multiple
Births Prob.
(ε )
/ % Twins

2.64

L&D PostDelivery
Care Time
(hours)

Min: 0.67
Mode: 1.5
Max: 2.0

Varies by day Varies by day
Min: 0.67
98.36%
and shift
and shift
3.28% / 100%
Mode: 1.5
(See Eqn. (3))
(See Table 6) (See Table 7)
Max: 2.0

Distribution
Distribution
Patient
of
of
Transport
L&D PostPatient
Time
Delivery
Transport
(hours)
Care Time
Time

D-C to
Distribution
Room Clean
of
No.
Time
D-C to
of PP
(hours) Room Clean Rms.
μ /σ
Time

PP LOS
(hours)
μ /σ

Varies by
Triangular Min: 0.33 Triangular
delivery type
based on Mode: 0.33 based on
and weekday
estimates Max: 0.50 estimates
(See Table 7)
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Varies by
Triangular Min: 0.33 Triangular
delivery type 1.73 / 1.27 Lognormal
based on Mode: 0.33 based on
and weekday 0.34 / 0.64 (See Fig. 9)
estimates Max: 0.50 estimates
(See Table 7)
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α = 0.05
Values after transformation
Data only available in IP2 due to enhanced data collection capability of new EHR, so analysis limited to Question #2

The rate of deliveries in each time period followed a non-homogenous Poisson
process (NHPP). As Hopp and Spearman (2008) indicated, a Poisson distribution is often
found to reasonably approximate counts of entity arrivals per unit of time. HRD data in
BL and IP2 are provided in Table 6.
Table 6: HRD Values by Weekday and Time Window for the DES Model
Time
Period

Time
Window

SUN

MON

TUE
2

THU
2

SAT

S
0.143

Ē
0.250

S
0.250

Ē
0.194

S
0.161

Ē
0.472

S
0.542

Ē
0.361

S
0.466

Ē
0.361

S
0.409

Ē
0.444

S2
0.425

2

0.278

0.263

0.361

0.294

0.194

0.161

0.500

0.486

0.556

0.425

0.472

0.485

0.250

0.250

3

0.333

0.286

0.972

0.885

0.833

0.943

0.889

1.016

1.000

0.571

0.722

0.549

0.472

0.485

4

0.333

0.286

0.722

0.606

0.667

0.571

0.861

0.809

1.139

1.094

0.861

0.809

0.583

0.364

5

0.417

0.421

0.611

0.644

0.694

0.675

0.750

0.821

0.806

0.904

0.611

0.473

0.500

0.543

6

0.389

0.359

0.500

0.486

0.861

0.637

0.528

0.599

0.694

0.675

0.667

0.686

0.306

0.218

1

0.278

0.263

0.278

0.263

0.389

0.359

0.250

0.193

0.639

0.694

0.306

0.275

0.278

0.378

2

0.250

0.250

0.556

0.540

0.472

0.371

0.500

0.486

0.472

0.485

0.611

0.473

0.389

0.302

3

0.306

0.390

0.833

0.600

1.083

0.993

0.722

0.492

0.889

0.444

0.694

0.504

0.417

0.364

4

0.583

0.650

0.694

0.561

0.639

0.637

0.667

0.686

0.806

0.618

1.139

0.694

0.556

0.540

5

0.361

0.352

0.611

0.644

0.667

0.857

0.639

0.523

0.833

0.771

1.083

1.050

0.472

0.599

6
0.194 0.275 0.444
Values approximate to a Poisson Distribution

0.368

0.500

0.600

0.639

0.466

0.556

0.597

0.528

0.656

0.500

0.371
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2

FRI

Ē
0.167

IP2

2

WED

1

BL

2

2

Devore (1995) stated that a property of a Poisson distribution is that variance (σ2)
and mean (μ) are equivalent, and this condition was not exactly met with the data in
Table 6 for values of sample variance (S2) and those of sample mean (Ē). Regression
equations with y-intercepts of zero were developed for time window mean HRD values to
predict variance values, and none of the assumptions for regression analysis defined in
Montgomery (2013) were violated. The slope in the regression equation for BL was
0.9339 with an R2adj value of 0.9710, and the slope for IP2 was 0.8808 with an R2adj value
of 0.9520. Since the slopes and R2adj values were each close to one, mean was found to
be a significant predictor of variance in both time periods.
The Poisson assumption for HRD values in IP2 was further tested by comparing
the simulated daily delivery values of the DES model created for IP2 to the to those
actually observed. Due to the limitation of data available for BL, such a model was not
created for BL. Figure 7 shows the spread of both data sets where the vertical lines
represent the first and fourth quartiles, the shaded rectangles represent the second and
third quartiles, and asterisks signify outlier data points.
Boxplot of Actual Deliveries vs. Simulated Deliveries for IP2
30

Daily Deliveries

25
20

15
10

5
0
Actual

Simulated

Figure 7: Boxplot of actual daily deliveries vs. simulated daily deliveries from the DES model for IP2
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A Two Sample t-Test was used to compare the mean value of the simulation to
that value of the actual IP2 data since both data sets were normally distributed. Also,
equal variances were assumed as an F-Test showed no significant difference (p = 0.459).
The Two-Sample t-Test found that the simulation mean value of 13.57 did not
significantly differ from the actual mean value of 13.56 (p = 0.986), so HRD values were
determined to reasonability fit Poisson distributions.
Multiple Births Probabilities were documented in Table 5 since it is the mother
who is delayed from receiving a PP room.

Multiple Births Probabilities were not

captured in BL as the data set did not include patient identifiers for mothers as did the
data set for IP2. Since all multiple births in IP2 were twins, Multiple Births Probability
(ε) for IP2 is the probability that the newborn is a twin.

The calculation for the

probability that a newborn is a single born or a lastborn twin (ψ) can be calculated using
Equation (3).
(

)

⁄

(3)

Where:

As stated in Table 5, parameter values for L&D Post-Delivery Care Time and
Patient Transport Time were based on estimates, which were provided by nursing leaders
as data were not available. Also, Kelton et al. (2015) recommended use of a triangular
distribution when practitioner estimates become necessary due to lack of data.
Table 7 provides information on the delivery type probabilities by weekday and
PP LOS parameters by delivery type and weekday of delivery. These parameters were
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assessed by weekday due to the scheduling tactic change, which limited scheduled
deliveries by delivery type on a daily basis as part of reducing the overall scheduled
deliveries allowed per day.
Table 7: Delivery Type and PP LOS Data by Weekday for the DES Model
Vaginal
Time
Period

BL

IP2

Day

SUN
MON
TUE
WED
THU
FRI
SAT
Total
SUN
MON
TUE
WED
THU
FRI
SAT
Total

Cesarean

PP LOS PP LOS p-value
% of Week's Number PP LOS PP LOS p-value
% of Week's Number
(Hours): (Hours): Fit with % Vaginal Vaginal
Vaginal (Hours): (Hours): Fit with % Cesarean Cesarean Cesarean
Ē
S
LN Dist.
Deliveries Deliveries
Ē
S
LN Dist.
Deliveries Deliveries
50.47
50.28
48.61
50.12
49.69
49.16
49.64
49.68
49.97
51.13
50.08
48.37
50.40
49.44
53.98
50.38

16.17
12.35
8.04
8.53
10.27
8.61
9.59
10.32
7.99
9.08
13.15
8.32
9.35
8.21
14.37
10.35

< 0.005
< 0.005
0.005
0.248
< 0.005
0.084
< 0.005
< 0.005
0.367
0.032
< 0.005
0.078
0.139
0.392
0.006
< 0.005

68.12%
57.72%
58.87%
66.67%
62.20%
60.90%
73.91%
63.37%
70.42%
62.60%
60.74%
68.03%
62.84%
60.26%
71.28%
64.31%

8.74%
13.20%
13.57%
17.84%
18.96%
15.06%
12.64%
100.00%
9.16%
14.10%
15.02%
15.20%
17.03%
17.22%
12.27%
100.00%

47
71
73
96
102
81
68
538
50
77
82
83
93
94
67
546

83.67
75.29
81.44
79.50
77.37
79.51
86.78
79.55
84.87
80.70
82.09
77.41
82.13
78.72
85.38
81.08

17.99
14.33
18.19
14.03
15.11
15.28
19.12
16.10
16.49
26.43
21.61
21.79
17.18
20.23
24.95
21.38

0.054
0.083
0.121
0.147
< 0.005
0.031
0.986
< 0.005
0.122
< 0.005
0.010
0.075
0.018
< 0.005
0.098
< 0.005

31.88%
42.28%
41.13%
33.33%
37.80%
39.10%
26.09%
36.63%
29.58%
37.40%
39.26%
31.97%
37.16%
39.74%
28.72%
35.69%

7.07%
16.72%
16.40%
15.43%
19.94%
16.72%
7.72%
100.00%
6.93%
15.18%
17.49%
12.87%
18.15%
20.46%
8.91%
100.00%

22
52
51
48
62
52
24
311
21
46
53
39
55
62
27
303

α = 0.05
Note: Data for delivery type was missing from the EHR report on five deliveries in IP2

A lognormal distribution was applied in the DES model to simulate PP LOS
values as only positive values are present in a lognormal distribution and PP LOS must
be positive. Half of delivery type and weekday combinations had PP LOS data that fit a
lognormal distribution as indicated in the columns titled “p-value Fit with LN Dist.” in
Table 7. Also, lognormal distribution probability plots of the combinations that did not
show statistical fit still demonstrated graphical fit with lognormal distributions.
The lognormal assumption for PP LOS was further tested in the DES model for
IP2 by comparing the distribution from the same simulation replication used for Figure 7
to the distribution of the actual data. Figure 8 shows the spread of both data sets where
the vertical lines represent the first and fourth quartiles, the shaded rectangles represent
the second and third quartiles, and asterisks signify outlier data points.
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Boxplot of Actual PP LOS vs. Simulated PP LOS for IP2
250

PP LOS (Hours)

200

150

100

50

0
Actual

Simulated

Figure 8: Boxplot of actual PP LOS vs. simulated PP LOS from the DES model for IP2

A Mood’s Median Test was used to compare the median PP LOS values of both
data sets since they were not normally distributed and contained outliers. The simulated
median value of 57.16 hours did not significantly differ from the actual median value of
54.83 hours (p = 0.058) and the spread of the data in Figure 8 was considered to be
similar, so the lognormal assumption for PP LOS was accepted.
Figure 9 shows the data for D-C to Room Clean Time graphically fit a lognormal
distribution between the 1st and 99th percentiles (i.e., CDF probabilities) of the IP2
distribution. Additional testing was not performed to further validate the lognormal
assumption due to the relatively small impact of D-C to Room Clean Time in the DES
model.
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Probability Plot of IP2 D/C to Room Clean Time (hour)
Lognormal - 95% CI

99.99

Loc
Scale
N
AD
P-Value

99

Percent

95

0.3360
0.6395
781
1.475
<0.005

80
50
20
5
1

0.01

0.1

1.0
D/C to Room Clean Time (hour)

10.0

Figure 9: Lognormal probability plot of D/C to Room Clean Time in IP2
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CHAPTER 5
MONTE CARLO SIMULATION MODEL

This Chapter 5 showcases use of the procedure proposed in Chapter 3 using
Monte Carlo simulation as defined by Anderson et al. (2006). Questions #1 and #2 were
addressed to determine the impact on Holds Rate for the case study detailed in Chapter 4.
The regression equation used by the MCS model was derived first to complete
Step 0.1. Next, a detailed explanation of Steps 1.1–1.6 is provided to demonstrate how a
single performance shift value was calculated.

Subsequently, Steps 1.7–1.9 were

completed to develop distributions of performance shift values and estimate the
probability that target performance would have been achieved in the baseline to answer
Question #1. This process was repeated for Steps 2.1–2.6 and for Steps 2.7–2.9 to
answer Question #2. Results are provided for all time periods and this Chapter 5 ends
with a discussion of the analysis. Questions #1 and #2 are restated below.

Question #1: If the scheduling rules of the IP1 and IP2 time periods existed in the
BL time period, how would the Holds Rate have differed in the BL time period?
Question #2: If the scheduling rules of the BL time period still existed in the IP1
and IP2 time periods, how would the Holds Rate have differed in the IP1 and IP2
time periods?
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5.1 Model Description for BL, IP1, and IP2
The regression equation was derived using the daily values of data summarized in
Table 4 for the RS time period. As shown in Table 3 and discussed in Chapter 4, four
variables were considered, but only the interaction term between B and C was found to be
significant. Variables A and C represented incoming demand to the PP unit, while B and
D were indicators of PP room utilization. These variables were considered for the
regression modeling process as both incoming demand and utilization of capacity are
generally known to be drivers of queue length and time spent in queue. Figure 10
provides the best subsets analysis that was performed to start the regression modeling
process.

Figure 10: Best subsets analysis for regression using all values of RS data
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As shown in Figure 10 with the red arrow, the subset chosen for further analysis
was the model using C*B and (C*B)2 as terms. These terms were chosen due to the high
adjusted R2 value with fewer variable terms as compared with other model subset
options. Figure 11 plots the fitted line of the regression model initially considered.
Fitted Line Plot: All Values of C*B Model
Holds Rate = 0.1700 - 0.000475 C*B
+ 0.000000 C*B**2

0.9

S
R-Sq
R-Sq(adj)

0.8

0.0928369
65.6%
65.0%

0.7
Holds Rate

0.6
0.5
0.4
0.3
0.2
0.1
0.0
0

500

1000

1500

2000

2500

C*B

Figure 11: Two term regression model to fit all values of RS data

However, this model was found to be inadequate as indicated by the residual plots
shown in Figure 12. A model’s adequacy must be supported by normally distributed
residuals that are independent in time order and have constant variance at fitted values as
indicated by Montgomery (2013).

While the residuals appeared to adhere to the

independence assumption in the residual vs. order plot, this model violated the normality
assumption as illustrated by the normal probability plot and the histogram. Regarding
variance of the residuals, the residual values appeared to be positively skewed in the
residual vs. fit plot indicating that variance was not constant.

65

Residual Plots for Holds Rate: All Values of C*B Model
Normal Probability Plot

Residual vs. Fit Plot
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Figure 12: Residual plots of two term regression model to fit all values of RS data

Upon further evaluation of Figure 11, the curved nature of the fitted regression
line appeared to be inappropriate as Holds Rate values tended to be zero with lower C*B
values. Figure 13 displays only three data points below 1200 in C*B value had a nonzero Holds Rate, where the vertical dashed line demarks 1200 in C*B value.
Furthermore, values of C*B above 1200 appeared to be positively correlated with higher
Holds Rate values as shown in Figure 13.
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Scatterplot of Holds Rate vs. C*B: Regression Study
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Figure 13: Scatterplot of Holds Rate vs. C*B for RS data

The best subsets analysis was repeated for the BL data using only C*B values
greater than 1200. In Figure 14, the red arrow points to the model selected for further
evaluation. This model was selected as it is linear and the non-linear alternatives each
violated the normality assumption associated with the distribution of the residuals.

Figure 14: Best subsets analysis for regression using RS data with C*B values >1200

Figure 15 shows the fit of the regression line among the BL data with C*B values
greater than 1200. The linear model was the best fit found over this range of data with
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the C*B term being statistically significant as p = 0.000 for the regression term in the
associated Analysis of Variance (ANOVA).
Fitted Line Plot: C*B > 1200 Model
Holds Rate = - 0.8730 + 0.000687 C*B
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Figure 15: Selected regression model to fit C*B values >1200 of RS data

Figure 16 confirms the model’s adequacy as none of the assumptions defined in
Montgomery (2013) were violated since normal distribution, time ordered independence,
and constant variance of the residuals were all supported. Figure 17 further validates the
normality assumption associated with the distribution of the residuals as p = 0.251 for the
normality test. Figure 17 plots the residuals for the 27 C*B values above 1200 in the RS
data (N = 27), with the X-axis being residual value and the Y-axis being CDF probability.
The middle line, which is straight, is the plot of a normal distribution and the curved lines
represent the upper and lower confidence intervals. As shown, all but one residual value
fell within the confidence intervals.
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Residual Plots for Holds Rate: C*B > 1200 Model
Residual vs. Fit Plot
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Figure 16: Residual plots of selected regression model

Normal Probability Plot of Residuals for C*B > 1200 Model
Normal - 95% CI
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Figure 17: Normal probability plot of residuals for selected regression model
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Based on the regression analysis, a two-stage MCS model was developed. C*B
values were used by determining 2 Days Deliveries (C) and Days D-C PP LOS (B),
where 2 Days Deliveries (C) was the summation of Daily Deliveries (A) for the subject
day and one day prior. This model is expressed in Equations (4) – (7).
Notations:

Holds Rate for day
2 Days Deliveries for day
Days D C PP LOS for day
Daily Deliveries for day
Holds for day (rounded to the nearest integer)
63 Day Holds Rate for 63 day period
The subset of days contained in 63 day period , where periods are non overlapping

Regression Model:
{

(

)

(4)
(5)
(6)

∑

⁄∑

(7)

In Equation (4), the Holds Rate (qi) is calculated for each day based on the
regression equation, which yields positive qi values for any C*B value that is at least
1,271. Therefore, qi is forced to zero for any C*B value below 1,271. Bi values are the
total time that all patients (mothers) discharged on day i stayed in the hospital following
delivery. For example, if 20 patients discharged with an average PP LOS of 3.5 days per
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patient, then the Bi value for that day would be 70 Days D-C PP LOS. Ci values are the
summation of the number of deliveries for day i (Ai) and the prior day’s value (Ai-1) as
defined by Equation (5). Equation (6) is used to calculate the total number of Holds (hi)
for each day by multiplying that day’s qi value by its Ai value and rounding the output
value to the nearest integer. In order to determine the 63 Day Holds Rate (Qj) for each 63
day period j, the summation of hi for days i
days i

Ij is divided by the summation of Ai for

Ij as defined by Equation (7).
As shown in Figure 18, Days D-C PP LOS (B) and 2 Days Deliveries (C) were

independent of one another due to a weak correlation coefficient that is statistically
insignificant. The Pearson correlation coefficient is also referred to as the correlation
coefficient and an absolute value below 0.5 is considered to be weak according to Devore
(1995). Also, Ci values were derived by adding successive Ai values from Equation (5),
so the data was investigated for autocorrelation. Autocorrelation between successive Ai
values is defined by Equation (8), which was derived from the formula for sample
correlation coefficient as documented in Devore (1995).
∑(
√ ∑

) (∑
(∑

)(∑

) √ ∑

)
(∑

)

(8)

Where:

(

)

Correlation was weak and statistically insignificant between successive Ai values
as displayed in Figure 19. Furthermore, there is no graphical evidence of any nonlinear
relationship in Figure 18 or Figure 19.

Therefore, Ci and Bi values could be

independently created for simulation by randomly generating values for Ai and Bi.
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Days D-C PP LOS (B) vs. 2 Days Deliveries (C)
Pearson correlation of B and C = -0.101, P-Value = 0.282
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Figure 18: Scatterplot of B vs. C for RS data

Autocorrelation of Daily Deliveries (A) between Successive Days
Pearson correlation of A(i) and A(i-1) = 0.176, P-Value = 0.059
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Figure 19: Scatterplot of Ai vs. Ai-1 for RS data
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25

30

5.2 Question #1: Experimental Design Demonstrated for IP1 vs. BL
The proposed analysis procedure for answering Question #1 begins with Step 1.1,
thus a simulation of Qj values was conducted using BL parameters as defined in Table 4.
The distribution of Qj values for T0 from the simulation is depicted in Figure 20, with the
red line marking the BL Overall Holds Rate (Y0).
Histogram of Q(j) Values for T(0)
Y(0) = 5.42%
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10.00%

Figure 20: Simulation output compared to BL Overall Holds Rate (Y0)

A normal transformed (Box-Cox λ = 0.5) was found to adequately represent the
distribution of 50 simulated Qj values for T0 with a very strong fit (p = 0.855). As seen in
Figure 20, the observed result was located near the center of the simulation distribution,
which was 58.48% of the cumulative normal transformed distribution in Step 1.2.
Therefore, the baseline CDF probability associated with BL was 0.5848.
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Figure 21 shows that the factor values of C*B in IP1 fell within the range used to
develop Equation (4). Thus, identifying a new relationship for Step 1.3 was unnecessary.
Range of C*B Values from IP1
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Figure 21: Histogram of C*B values for IP1 data

Step 1.4 was accomplished using 50 simulation replications to generate Qj values
by applying Equations (4) – (7) and randomly generating values for Bi and Ai. As shown
in Table 2, the scheduling rules changed in IP1. Subsequently, the variability of volumes
in the L&D and PP units was reduced in IP1. This impact was measured by each
variable’s coefficient of variation (CV), which is defined as the standard deviation
divided by the mean value of a random variable as documented by Hopp and Spearman
(2008). Table 8 shows the CV’s for variables A and B in both the BL (T0) and IP1 (T1)
time periods.
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Table 8: CV Calculation for BL (T0) and IP1 (T1)
Parameter

Value

Distribution / Comments

T0 Mean Daily Total Deliveries (A)

13.48

Normal (See Table 4 for BL)

T0 Stdev Daily Total Deliveries (A)

5.17

Normal (See Table 4 for BL)

T0 CV (A)

0.3839

Mean / Stdev

T0 Mean Days D-C PP LOS (B)

34.89

Normal (See Table 4 for BL)

T0 Stdev Days D-C PP LOS (B)

12.28

Normal (See Table 4 for BL)

T0 CV (B)

0.3520

Mean / Stdev

T1 Mean Daily Total Deliveries (A)

13.51

Normal (See Table 4 for IP1)

T1 Stdev Daily Total Deliveries (A)

4.94

Normal (See Table 4 for IP1)

T1 CV (A)

0.3658

Mean / Stdev

T1 Mean Days D-C PP LOS (B)

33.16

Normal (See Table 4 for IP1)

T1 Stdev Days D-C PP LOS (B)

11.15

Normal (See Table 4 for IP1)

T1 CV (B)

0.3364

Mean / Stdev

Since the scheduling rules introduced in IP1 were intended to reduce the
variability of volumes in the L&D and PP units, the respective CV’s associated with A
and B were determined to be factors influenced by the change (i.e., controlled
parameters). However, overall delivery volumes and subsequent demand for PP care
were not controlled by scheduling. Therefore, standard deviation values of A and B were
deemed to be affected by the scheduling tactic change, whereas mean values of A and B
were not. Table 9 outlines the parameter values for T0′.
Table 9: T0′ Parameter Values for the MCS Model
Parameter

Value

Distribution / Comments

T0' Mean Daily Total Deliveries (A)

13.48

Normal (uncontrolled, same as BL)

T0' Stdev Daily Total Deliveries (A)

4.93

Normal (calculated as CV is controlled parameter)

T0' CV (A)

0.3658

Controlled in IP1

T0' Mean Days D-C PP LOS (B)

34.89

Normal (uncontrolled, same as BL)

T0' Std Dev Days D-C PP LOS (B)

11.74

Normal (calculated as CV is controlled parameter)

T0' CV (B)

0.3364

Controlled in IP1
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The parameter values in Table 9 were used in the 50 simulation replications to
generate Qj values that were used along with the baseline CDF probability to determine
Y0′. The distribution of simulated Qj values for T0′ was found to be normal transformed
(Box-Cox λ = 0.5) with a strong fit (p = 0.576). The baseline CDF probability and the
inverse of the CDF for the normal transformed distribution were used together to
calculate a transformed Y0′ value (Y0′t). The transformed Y0′ value was squared to find
Y0′ in Step 1.5. Subsequently, Y0 was compared to Y0 in Step 1.6 of the analysis. Table
10 details the values pertinent to the calculations for Steps 1.5 and 1.6.
Table 10: Calculation of Y0′ and % Y0′ Improved over Y0 for Holds Rate
Variable

Value

BL CDF Probability

0.5848

Mean
Stdev

Qjt for T0'
Qjt for T0'

Y0't Using BL CDF

Probability

20.92%
3.92%
21.76%

Step 1.5 Y0' Using BL CDF Probability

4.73%

BL Holds Rate (Y0)

5.42%

Step 1.6 % Y0' Improved over Y0

12.6%

A distribution of 50 comparison values was developed in Step 1.7 by repeating
Steps 1.1–1.6. Also, each simulation applied common random numbers (CRN) as part of
a variance reduction technique shared in Kelton et al. (2015). This distribution was found
to be normal (p = 0.392). As shown in Figure 22, the baseline performance shift CDF
probability was one, or 100% of the cumulative normal distribution, in Step 1.8. The
targeted performance shift of 15% is represented by the lower specification limit (LSL)
since the targeted performance shift represents the minimal amount of improvement
required. Any value below the LSL is counted to the parts per million (PPM) total, where

76

PPM is a measure of how many trials (parts) are expected to be non-conforming out of
one million trials.
Process Capability of %Y(0') Improved over Y(0)
LSL represents targeted performance shift (15%)
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14

Within
Overall

12
P rocess
LS L
Target
USL
S ample M ean
S ample N
S tDev (Within)
S tDev (O v erall)

Frequency

10
8
6

Data
0.15
*
*
0.11071
50
0.00642029
0.00662246

4
2
0

0.096 0.104 0.112 0.120 0.128 0.136 0.144
Performance Shift

O bserv ed P erformance
P P M < LS L
1000000.00
PPM > USL
*
P P M Total
1000000.00

E xp. Within P erformance
P P M < LS L
1000000.00
PPM > USL
*
P P M Total
1000000.00

E xp.
PPM
PPM
PPM

O v erall P erformance
< LS L
1000000.00
> USL
*
Total
1000000.00

1,000,000 / 1,000,000 = 100%

Figure 22: Baseline performance shift CDF probability for Holds Rate

In order to complete Step 1.9, the result of Step 1.8 was subtracted from one.
Thus, there is a probability of zero that the actual Holds Rate performance observed
during BL (Y0) could have been at least 15% lower had the L&D schedule been managed
in BL as it was in IP1 (Y0′). However, further review of the information presented in
Figure 22 indicated that Holds Rate performance could have been at least 9% lower in
BL had the L&D scheduled been managed as it was in IP1. These statements provided
the answer to Question #1 and it was substantiated by the distribution found in Step 1.7,
which is shown in Figure 22.
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5.3 Question #2: Experimental Design Demonstrated for IP1 vs. BL
The proposed analysis procedure for answering Question #2 begins with Step 2.1,
which is identical to Step 1.3. As shown in Figure 21 and discussed in Section 5.2, the
factor values of C*B in IP1 fell within the range used to develop Equation (4). Thus,
identifying a new relationship for Step 2.1 was unnecessary.
To complete Step 2.2, a simulation of Qj values was conducted using IP1
parameters as defined in Table 4. The distribution of Qj values for T1 from the simulation
is depicted in Figure 23, with the red line marking the IP1 Overall Holds Rate (Y1).
Histogram of Q(j) Values for T(1)
Y(1) = 5.29%
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Figure 23: Simulation output compared to IP1 Overall Holds Rate (Y1)

A normal transformed (Box-Cox λ = 0.5) was found to adequately represent the
distribution of 50 simulated Qj values for T1 with a very strong fit (p = 0.896). As seen in
Figure 23, the observed result was located near the mode of the simulation distribution,
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and was 74.44% of the cumulative normal transformed distribution in Step 2.3.
Therefore, the post-change CDF probability associated with IP1 was 0.7444.
Step 2.4 was accomplished using 50 simulation replications (Qj values) applying
Equations (4) – (7) and randomly generating values for Bi and Ai. As discussed in
Section 5.2, the scheduling rules changed in IP1 and the variability of volumes in the
L&D and PP units was reduced as intended. Accordingly, the respective CV’s for A and
B were determined to be factors influenced by the change (i.e., controlled parameters),
while overall delivery volumes and subsequent demand for PP care were not controlled
by scheduling. Therefore, standard deviation values of A and B were to be affected by
the scheduling tactic change, while mean values of A and B were not. Table 11 outlines
the parameter values for T1′.
Table 11: T1′ Parameter Values for the MCS Model
Parameter

Value

Distribution / Comments

T1' Mean Daily Total Deliveries (A)

13.51

Normal (uncontrolled, same as IP1)

T1' Stdev Daily Total Deliveries (A)

5.19

Normal (calculated as CV is controlled parameter)

T1' CV (A)

0.3839

Controlled in BL

T1' Mean Days D-C PP LOS (B)

33.16

Normal (uncontrolled, same as IP1)

T1' Std Dev Days D-C PP LOS (B)

11.67

Normal (calculated as CV is controlled parameter)

T1' CV (B)

0.3520

Controlled in BL

The parameter values in Table 11 were used in the 50 simulation replications to
generate Qj values used along with the post-change CDF probability to determine Y1′.
The distribution of simulated Qj values for T1′ was found to be normal transformed (BoxCox λ = 0.5) with a strong fit (p = 0.651). The post-change CDF probability and the
inverse of the CDF for the normal transformed distribution were used together to
calculate a transformed Y1′ value (Y1′t). The transformed Y1′ value was squared to find
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Y1′ in Step 2.5. Subsequently, Y1 was compared to Y1′ in Step 2.6 of the analysis. Table
12 details the values pertinent to the calculations for Steps 2.5 and 2.6.
Table 12: Calculation of Y1′ and % Y1 Improved over Y1′ for Holds Rate
Variable

Value

IP1 CDF Probability

0.7444

Mean
Stdev

Qjt for T1'
Qjt for T1'

Y1't Using IP1 CDF

Probability

21.01%
5.27%
24.47%

Step 2.5 Y1' Using IP1 CDF Probability

5.99%

IP1 Holds Rate (Y1)

5.29%

Step 2.6 % Y1 Improved over Y1'

11.7%

A distribution of comparison values was developed in Step 2.7 with 50 repetitions
of Steps 2.1–2.6. Also, each simulation applied common random numbers (CRN) as part
of a variance reduction technique shared in Kelton et al. (2015). This distribution was
found to be normal with a very strong fit (p = 0.988). As shown in Figure 24, the postchange performance shift CDF probability was 0.9999, or 99.99% of the cumulative
normal distribution, in Step 2.8. The targeted performance shift of 15% is represented by
the lower specification limit (LSL) since the targeted performance shift represents the
minimal amount of improvement required. Any value below the LSL is counted to the
parts per million (PPM) total, where PPM is a measure of how many trials (parts) are
expected to be non-conforming out of one million trials.
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Figure 24: Post-change performance shift CDF probability for Holds Rate

In order to complete Step 2.9, the result of Step 2.8 was subtracted from one.
Thus, there is a probability of 0.0001 that the actual Holds Rate performance observed
during IP1 (Y1) could have been at least 15% lower than it would have been had the L&D
schedule been managed in IP1 as it was in BL (Y1′). However, further review of the
information presented in Figure 24 indicated that Holds Rate performance could have
been at least 9% lower in IP1 than if the L&D scheduled had been managed as it was in
BL. These statements provided the answer to Question #2 and it was substantiated by the
distribution found in Step 2.7, which is shown in Figure 24.

5.4 Results for IP1 vs. BL and IP2 vs. BL
The analyses detailed in Sections 5.2 and 5.3 were replicated to compare the
performance of IP2 to that of BL. Figure 25 shows that the factor values of C*B in IP2
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fell within the range used to develop Equation (4). Thus, identifying a new relationship
for Steps 1.3 and 2.1 was unnecessary.
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Figure 25: Histogram of C*B values for IP2 data

In IP2, the Overall Holds Rate (Y1) was only 3.28%, which marked a 39.48%
improvement over the BL Overall Holds Rate (Y0). However, as shown in Figure 26, the
observed result was located to the left of the simulation distribution’s center, with a postchange CDF probability of 0.3166. The baseline CDF probability associated with BL
was 0.5348, so the amount that the IP2 Overall Holds Rate (Y1) improved over the BL
Overall Holds Rate (Y0) appeared to be caused by more than the scheduling tactic change
alone. As will be shown, the proposed procedure addressed this concern by using the
baseline CDF probability to answer Question #1 and by using the post-change CDF
probability to answer Question #2. As stated in Chapter 3, a CDF probability is a
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measure of chance, and using these CDF probabilities isolates the chance associated with
each time period under analysis.
Histogram of Q(j) Values for T(1)
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Figure 26: Simulation output compared to IP2 Overall Holds Rate (Y1)

Table 13 details the observed Holds Rate improvement versus those values
determined by following the proposed procedure.

As shown, the difference in

performance shift from BL to IP1 compared to that from BL to IP2 was much smaller
using the results from the proposed procedure as compared to the observed results. These
results indicated that uncontrolled factors influencing the Holds Rate in IP1, including
those attributed to chance, contributed a negative effect. Conversely, the uncontrolled
factors in IP2 made a positive impact. However, the difference in performance caused by
the controllable factors, which are variation in Daily Deliveries and the PP LOS
associated with the PP discharges for each day (Days D-C PP LOS), had a more
consistent and positive impact between IP1 and IP2.
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Table 13: Observed Holds Rate Improvement Values Compared to Procedure-Derived Values
Time Period
Y0
Y1
%Y1 Improved over Y0
Comparison (Observed) (Observed) (Observed Performance Shift)

IP1 vs. BL

5.42%

5.29%

2.40%

%Y0' Improved over Y0

%Y1 Improved over Y1'

(Procedure for Question #1)

(Procedure for Question #2)

Ē = 11.07%
S = 0.66%
n = 50 comparisons
Prob. Target Achieved = 0.0000
Ē = 20.12%
S = 0.59%
n = 50 comparisons
Prob. Target Achieved = 1.0000

Ē = 11.58%
S = 0.85%
n = 50 comparisons
Prob. Target Achieved = 0.0000
Ē = 21.09%
S = 0.98%
n = 50 comparisons
Prob. Target Achieved = 1.0000

IP2 vs. BL
5.42%
3.28%
39.48%
α = 0.05, Power = 1.00 (β = 0.00)
H a for One-Sample t Test is µ > 15% (targeted performance shift)

As shown in Table 13, 50 sample comparisons were made from the proposed
procedure to assess %Y0′ Improved over Y0 and to assess %Y1 Improved over Y1′ for
both time period comparisons. This yielded a statistical power of 1.00 for each OneSample t Test performed when seeking to detect a difference in the mean value for
performance shift of 1%. This 1% value was chosen since the sample mean values of
each time period comparison were more than two percentage points different than the
targeted performance shift of 15%. Thus, there was a probability of one to conclude that
the mean was greater than 15% (i.e., reject H0) when indeed the mean was greater than
15% (i.e., H0 is false). In the IP2 vs. BL comparison, the p-value of each One-Sample t
Test was 0.000, thereby indicating a probability of zero to conclude that mean
performance shift was greater than 15% (i.e., reject H0) when indeed it was no different
than 15% (i.e., H0 is true). However, in the IP1 vs. BL comparison, the p-value of each
One-Sample t Test was 1.000, thereby indicating a probability of one to conclude that the
mean performance shift was greater than 15% (i.e., reject H0) when indeed it was no
different than 15% (i.e., H0 is true). These observations, combined with the Probability
Target Achieved values in Table 13, led to the conclusion that target performance for
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Holds Rate was not achieved in the IP1 vs. BL comparison and it was exceeded in the IP2
vs. BL comparison.
A sample size of 50 comparisons was used for each time period analysis though a
smaller sample size could have been used. Also, each simulation run consisted of 50
replications, while fewer replications would have been sufficient. While a sample size
(n) requirement is determined by the statistical power achieved, estimating the error of
the simulation sample mean relative to the population mean (γ) is an objective approach
to determining the number of replications (m) needed in each simulation run. Law (2007)
provided mathematical relationships for the method of estimating γ to determine the
required value of m as expressed in Equations (9) – (12).
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In Equation (9), the population mean (μ) is unknown despite the simulation
sample mean based on m replications being known, which is denoted as Ē(m). Therefore,
γ cannot be directly calculated in Equation (9), so Equations (10) and (11) are necessary.
In Equation (10), δ(m, α) is the confidence interval half-length for μ based on m
replications and α, and Equations (5) and (6) are used together in an iterative process to
determine the required m to achieve an adjusted relative error (γ′) that results in a
sufficient γ. A larger m results in longer simulation run times, but also yields a smaller γ
and a tighter confidence interval, which is denoted in Equation (12) as I(α, γ).
To demonstrate the impact of m and n on γ′, γ, and statistical power, values of m
and n were varied in an analysis of %Y1 Improved over Y1′ for IP2 vs. BL as documented
in Table 14. Case I is the same comparison made for IP2 vs. BL and Question #2 in
Table 13. Min γ′ is the minimal value of γ′ required to satisfy Equation (11) for all
comparisons with simulations of replication length m and sample size n listed. Min γ was
calculated by algebraic conversion of Equation (11).
Table 14: Results of IP2 vs. BL for Holds Rate Using Different Replication Lengths and Sample Sizes
Case

Replications Samples
Min γ'
(m )
(n )

Min γ

%Y1 Improved over Y1'
(Procedure for Question #2)

Case I

50

50

0.1428 0.1666

Ē = 21.09%
S = 0.98%
Actual Power = 1.0000

Case II

30

30

0.2116 0.2683

Ē = 21.43%
S = 1.45%
Actual Power = 0.9794

Case III

25

30

0.2238 0.2883

Ē = 21.23%
S = 1.19%
Actual Power = 0.9978

Case IV

20

30

0.2920 0.4125

Ē = 21.50%
S = 1.35%
Actual Power = 0.9897

Case V

20

20

0.2506 0.3344

Ē = 21.24%
S = 1.30%
Actual Power = 0.9932

α = 0.05, Target Power = 0.95 (β = 0.05)
H a for One-Sample t Test is µ > 15% (targeted performance shift)
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The probability that the target was achieved was one for each case in Table 6.
Also the actual statistical power of the One-Sample t-Test performed in each case was
approximately one while the p-value of each One-Sample t-Test was zero. Therefore,
there was near certainty in correctly concluding that the mean value for performance shift
was greater than 15% in each case. Fairly large values of Min γ were obtained without
sacrificing the actual statistical power associated with the comparison made in Step 2.9,
and this was attributed to the relatively small standard deviation associated with the
comparison values as a result of using the CRN variance reduction technique.
In Table 6, the five cases presented show that varying m and n impact Min γ (γ′).
Cases II–IV have n fixed at 30, and the values of Min γ (γ′) are inversely related to m,
which was expected based on Equations (10) and (11) since δ(m,α) increases as m
decreases when all other parameters are held constant. Also, n impacts Min γ (γ′) as
shown in Cases IV and V, and this is due a larger sample size allowing for a broader
range of γ (γ′) values.

5.5 Discussion
As mentioned in Section 5.4, uncontrolled factors influencing the Holds Rate in
IP1 contributed a negative effect, while those in IP2 made a positive impact. Though not
indicative of the targeted performance shift of 15% being achieved, the results of the
proposed procedure for the IP1 vs. BL comparison were nearly five times greater than the
observed performance shift of IP1 vs. BL. Thus, the scheduling tactic change was more
effective than the observed performance showed. As stated in Section 1.1, a less-refined
version of the proposed procedure demonstrated to hospital leadership that the change
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was more effective than what was observed in the Holds Rate data. This analysis allowed
leaders to continue their support of the scheduling tactic change. Thus, the proposed
procedure can allow organizations to quantitatively assess the effectiveness of a change
while accounting for unfavorable influence from the uncontrolled environment.
Alternatively, the results in Table 13 for IP2 vs. BL show that the observed
performance far exceeded the targeted performance shift of 15%. However, the proposed
procedure yielded results much closer to that goal. Therefore, the proposed procedure
can allow organizations to quantitatively assess the effectiveness of a change while
accounting for favorable influence from the uncontrolled environment.
The new scheduling rules reduced the CV’s of Daily Deliveries and Days D-C PP
LOS by up to 5% in IP1 and 8% in IP2. This reduction allowed the flow of patients into
the system to be smoothed. Patients were less likely to be held as indicated by the results
of the analysis with the proposed procedure, and this correlates to higher patient
satisfaction. Nurses and physicians were burdened less than they were in BL on peak
days of volume in L&D and PP due to the smoothed patient flow. In fact, both the
hospital’s chief administrative officer (CAO) and the System Vice President (SVP) of
Women’s Services at NHC have heralded this project as successful.
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CHAPTER 6
DISCRETE-EVENT SIMULATION MODEL

This Chapter 6 provides an example of the procedure proposed in Chapter 3 being
applied using discrete-event simulation. Only Question #2 was addressed to determine
the impact on ADT for the case study detailed in Chapter 4, and this was due to the
limitations of data available prior to the new EHR being implemented.
A DES model was developed to complete Step 0.1. Next, a detailed explanation
of Steps 2.1–2.6 is provided to demonstrate how a single performance shift value was
calculated. Subsequently, Steps 2.7–2.8 were completed to develop a distribution of
performance shift values and estimate the mean change in performance. Step 2.9 was not
performed since no targeted performance shift was set. Results are provided for the IP2
vs. BL comparison made in Step 2.8 and this Chapter 6 ends with a discussion of the
analysis. Question #2 is restated below.

Question #2: If the scheduling rules of the BL time period still existed in the IP2
time period, how would ADT have differed in the IP2 time period?
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6.1 Model Description for BL and IP2
Figure 27 depicts the basic structure of patient flow for BL and IP2, and a DES
model was implemented using Arena. In the model, entities flowed through the model
such that PP bed assignment and duration of PP bed seizure were accurately captured.

Delivery

Singleton or
Last Twin?

Yes

Wait for PP Bed
to be Assigned

No

Wait < 2
Hours?

Yes

No
Transport to PP
Bed and Hand-off

First Twin

Determine
Weekday of
Delivery

Delivery
Method?

Weekday determined by
series of two way by
condition decision types

Finish PostDelivery Care in
L&D

Vaginal

Cesarean

Time in PP Unit for
Vaginal Delivery on
Weekday

Mother
Discharged

PP Room
Cleaned

PP Bed
Ready for
Next Use

Time in PP Unit for
Cesarean Delivery on
Weekday

Figure 27: Basic structure of the DES model



First, entities arrive in the model as newborn deliveries. Since the mother is
assigned a PP bed, the newborn entity is represented as a mother patient. This is
accomplished immediately following the Delivery step as the probability of the
newborn being a singleton (i.e., single birth) or lastborn twin is applied in the
subsequent decision point. The entity exits the model if it is a firstborn twin so as
to only allow the mother to move forward since she is associated by proxy with
the lastborn twin.
assigned to her.

Following delivery, each mother waits to have a PP bed
The mother entity then seizes the PP bed resource when

departing this queue despite not yet being transported to the PP unit. The PP bed
is seized before transport as each mother patient has claim to her assigned PP bed
at this point.
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If a mother happens to wait less than two hours to seize a PP bed, then more time
is added to the delay so post-delivery care is finished before transporting the
patient since such care can take from 40 minutes to two hours. Post-delivery care
includes activities such as weighing the baby, cutting the umbilical cord, and
placental expulsion. It is possible for a mother entity to wait just under two hours
and then incur an additional two hours of post-delivery care, but the impact of this
on the results was negligible. However, each mother entity is delayed at least 40
minutes from being transported to her PP bed in the model, and this reflects the
actual process. Transporting each mother to her PP bed includes conducting a
nursing hand-off.



Once the mother arrives to her PP bed, her weekday of delivery and method of
delivery are determined due to their impacts on PP LOS. The probability of
vaginal delivery is based on the weekday of delivery. The duration of time in the
PP unit is measured by subtracting the entity’s time between delivery and being
transported to the PP bed from the entity’s PP LOS. Time in the PP unit accounts
for various clinical and non-clinical activities, which include the mother’s
recovery, vaccinations, circumcision as requested, hearing screens, lactation
consults, governmental documentation, and a car seat test.



After completion of her time in the PP unit, the mother is discharged and the
entity turns into a room cleaning need. The time to clean the PP room includes
the response time of environmental services staff to the cleaning request in
addition to the time spent cleaning the room. Upon the PP room being cleaned,
the PP bed is released for a future use in the model.
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Aside from the model’s structure, the model involved steady-state simulation
since the mother baby service line continuously operated. Thus, prior to completing
Steps 0.1 and 2.1, a warm-up period needed to be established with a duration that allowed
for stabilization to occur as indicated by Kelton et al. (2015). Both the number of
occupied PP beds and the average delay time between delivery of a singleton or last born
twin and the mother being placed into a PP bed (ADT) were examined to determine the
appropriate number of days in the simulation needed for the warm-up period. Only IP2
data was used for this assessment since not all required data points were available to
make such an assessment for BL.
The number of occupied PP beds was counted at every midnight in the simulation
following the start, which is consistent with the method for measuring census level at
Norton Healthcare. Daily delivery volumes fluctuated by weekday, as did census levels
routinely throughout each week. Therefore, census level values needed to be compared
by weekday in order to assess when steady-state was reached in the simulation. The
difference between each day’s census and the average census for that weekday over the
weeks remaining in each simulation replication was measured to identify stability. Mean
differences across 50 replications were plotted over simulation days in Figure 28, and the
results indicated mean differences approached zero.
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Figure 28: Plot of mean difference from average census by weekday in IP2 simulation

Mean ADT values were calculated over 50 replications to measure delays
between mother’s delivery and her placement in a PP bed. Due to delivery volumes
fluctuating by weekday, mean ADT values were also analyzed by weekday as shown in
Table 15. The mean ADT value for only Sunday of Week 1 was identified to be lower
than all of those values of the remaining weeks.
Table 15: Mean ADT Values by Weekday in IP2 Simulation
Week #
1
2
3
4
5
6
7
8
9
10

SUN
1.73
2.33
2.18
2.06
2.04
1.85
2.44
2.23
2.51
2.61

MON
1.80
1.78
1.78
1.79
1.79
1.77
1.80
1.83
1.76
1.77

TUE
1.83
1.82
1.86
1.76
1.81
1.80
1.91
1.97
1.79
1.78

WED
2.19
2.02
2.23
1.85
2.13
2.36
2.22
2.13
1.81
2.31

THU
2.33
2.44
2.17
2.10
2.49
2.02
2.48
2.20
2.04
2.64

FRI
3.30
3.43
2.72
3.05
3.20
2.89
3.07
2.57
3.36
3.36

SAT
3.20
3.64
2.93
2.98
3.20
2.69
2.84
2.90
3.47
3.58

Based on the trends observed in Figure 28 and Table 15, a warm-up period of
seven days was determined to be sufficient for stability to be achieved in the model.
While a shorter warm-up period of four or five days could have been considered, seven
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days allowed for additional assurance that individual replications would achieve steadystate prior to output data being reported.

6.2 Question #2: Experimental Design Demonstrated for IP2 vs. BL
After having developed a suitable model for both BL and IP2 to fulfill the
requirements of Steps 0.1 and 2.1, the proposed analysis procedure for answering
Question #2 advanced to Step 2.2. To complete Step 2.2, a simulation of ADT values
was conducted using IP2 parameters as defined in Tables 5–7. The distribution of ADT
values for T1 from the simulation is depicted in Figure 29, with the red line marking the
IP2 ADT value (Y1).
Histogram of ADT Values for T(1)
Y(1) = 2.64
40

Frequency

30

20

10

0

2.0

2.5

3.0

3.5
ADT (Hours)

4.0

4.5

5.0

Figure 29: Simulation output compared to IP2 ADT value (Y1)

A normal transformed distribution which used Equation (13) in the Johnson
transformation (JT) method was found to adequately represent the distribution of 125
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simulated ADT values for T1 with acceptable fit (p = 0.083). The number of simulation
replications (m = 125) was determined using Equations (9) – (12) and a relative error γ
equal to 0.10. This target value of γ was selected since a One Sample t-Test and
statistical power calculation were not practical as a targeted performance shift was not
specified for ADT. Also, the lack of a targeted performance shift for ADT resulted in the
analysis being terminated at Step 2.8. The value of m was incremented by 25 until an
acceptable value was found for all simulation samples used in the analysis to answer
Question #2. Min γ at 125 replications was 0.0845, so the target γ of 0.10 was achieved.
As seen in Figure 29, the observed result was 74.83% of the cumulative normal
transformed distribution in Step 2.3.

Therefore, the post-change CDF probability

associated with IP2 was 0.7483.
(

)

(13)

Where:
T value of ADT
ADT value to be transformed
Minimum value of ADT across all replications
Maximum value of ADT across all replications

In Step 2.4, 125 simulation replications (ADT values) were used and all
parameters of the DES model had the same values as those of IP2 with the exception of
HRD values and weekday delivery type probabilities. The scheduling tactic change
limited scheduled deliveries by delivery type on a daily basis as part of reducing the
overall scheduled deliveries allowed per day. Thus, HRD values and probabilities of
vaginal delivery by weekday were considered as factors influenced by the change (i.e.,
controlled parameters), while other parameters were not.
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Equation (14) was used to estimate HRD parameters for T1′ that reflected the
volume variability of BL in an NHPP since volume variability was controlled by the
scheduling tactic change. Also, the process needed to have a value for overall mean daily
deliveries equal to that of IP2 as overall delivery volume was deemed to be an
uncontrolled parameter.
̅

(14)

Where:
Index for time window
Index for weekday
̅

HRD parameter for use in time window

on weekday

in

Mean of daily deliveries for
Proportion of deliveries occurring on weekday
Proportion of deliveries in

in BL
in BL

Scaling factor for weekdays per week (7)
Number of hours per time window ( )

In Equation (14), the mean daily deliveries for IP2 (μ = 13.56) were multiplied by
a scaling factor (τ = 7) to determine the mean volume of weekly deliveries in IP2. The
mean volume of weekly deliveries in IP2 was multiplied by the proportion of deliveries
that occurred on weekday h (θh) in BL to estimate the mean daily deliveries for weekday
h in T1′. The estimate of mean daily deliveries for weekday h was multiplied by the
proportion of deliveries for weekday h that occurred during time window g on weekday h
in BL (ωg,h) to estimate the mean amount of deliveries that occurred during time window
g on weekday h in T1′. Finally, the estimate of the mean amount of deliveries that
occurred during time window g on weekday h was divided by the number of hours per
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time window (ρ = 4) to estimate the HRD parameter for use in time window g on
weekday h in T1′ (Ēg,h). Values of θh are shown in Figure 30 and values of ωg,h are shown
in Table 16. Table 17 provides the Ēg,h values calculated using Equation (14).

Figure 30: Bar graph of θh values

Table 16: Table of ωg,h Values
Time
Window
1
2
3
4
5
6

SUN
0.087
0.145
0.174
0.174
0.217
0.203

MON
0.073
0.106
0.285
0.211
0.179
0.146

TUE
0.056
0.056
0.242
0.194
0.202
0.250

WED
0.118
0.125
0.222
0.215
0.188
0.132

THU
0.079
0.122
0.220
0.250
0.177
0.152

FRI
0.098
0.128
0.195
0.233
0.165
0.180

SAT
0.174
0.098
0.185
0.228
0.196
0.120

Table 17: Table of Ēg,h Values
Time
Window
1

SUN
0.168

MON
0.252

TUE
0.196

Ē
WED
0.475

THU
0.363

FRI
0.363

SAT
0.447

2

0.280

0.363

0.196

0.503

0.559

0.475

0.252

3

0.335

0.978

0.839

0.894

1.006

0.727

0.475

4

0.335

0.727

0.671

0.866

1.146

0.866

0.587

5

0.419

0.615

0.699

0.755

0.811

0.615

0.503

6

0.391

0.503

0.866

0.531

0.699

0.671

0.307
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Probabilities of vaginal delivery by weekday for T1′ were estimated with data
from Table 7. First, the total Number of Vaginal Deliveries in IP2 was multiplied by the
% of Week’s Vaginal Deliveries for each weekday in BL and rounded to the nearest
integer to estimate the Number of Vaginal Deliveries for each weekday in T1′. This
operation was done since the scheduling tactic change affected the distribution of
deliveries across weekdays for each delivery type. This estimate for each weekday was
then divided by the summation of the total Number of Vaginal Deliveries in IP2 and the
total Number of Cesarean Deliveries in IP2 to calculate the Estimated Probability of
Vaginal Delivery by weekday for T1′. Table 18 provides the Estimated Probability of
Vaginal Delivery by weekday for T1′.
Table 18: Estimated Probability of Vaginal Delivery by Weekday for T1′

Day
SUN
MON
TUE
WED
THU
FRI
SAT
Total

Estimated
Estimated Estimated
Prob. of
Vaginal Cesarean
Vaginal
Deliveries Deliveries
Delivery
69.57%
48
21
58.54%
72
51
59.68%
74
50
67.36%
97
47
63.41%
104
60
61.65%
82
51
75.00%
69
23
64.31%
546
303

The parameter values in Tables 17 and 18 were used with all other parameter
values from IP2 to generate ADT values for T1′. The ADT values for T1′ were found to
be normal transformed using Equation (13) with acceptable fit (p = 0.061), and this
distribution was used along with the post-change CDF probability to determine Y1′. The
post-change CDF probability and the inverse of the CDF for the normal transformed
distribution were used together to calculate a transformed Y1′ value (JT Value of Y1′).
The transformed Y1′ value was used in a routine using Excel Solver to calculate Y1′ in
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Step 2.5. Subsequently, Y1 was compared to Y1′ in Step 2.6 of the analysis. Table 19
details the values pertinent to the calculations for Steps 2.5 and 2.6.
Table 19: Calculation of Y1′ and % Y1 Improved over Y1′ for ADT

Variable

Value

IP2 CDF Probability

0.7483

Mean JT Value of ADT for T1'

-0.2330

Stdev JT Value of ADT for T1'

0.8750

JT Value of Y1' Using IP2 CDF Probability

0.3526

Step 2.5 Y1' Using IP2 CDF Probability

2.88

IP2 ADT (Y1)

2.64

Step 2.6 % Y1 Improved over Y1'

8.2%

A distribution of comparison values (Δ1/1′ values) was developed in Step 2.7 with
32 repetitions of Steps 2.1–2.6 to generate 32 sample observations.

Samples were

increased in the increment of 16 as simulation runs in Arena were made with 2,000
replications each to generate 16 samples of 125 replications each. A target γ of 0.10 was
selected for the mean value of Δ1/1′, and Equations (9) – (12) were applied by substituting
n in place of m in the equations. The target γ was achieved after generating 32 samples,
which resulted in a γ value of 0.0759.
Each simulation applied common random numbers (CRN) as part of a variance
reduction technique shared in Kelton et al. (2015). This distribution was found to be
normal with a very strong fit (p = 0.754). As shown in Figure 31, the mean value of Δ1/1′
was 10.742%, with a 95% confidence interval of (9.984%, 11.499%).

Also, the

comparison values from the simulation ranged between 6.691% and 15.917%, and this
indicates that the scheduling tactic change reduced ADT from what it would have been if
the scheduling tactics from BL were still in use in IP2. These statements provided the
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answer to Question #2 and it was substantiated by the distribution of Step 2.7 as shown in
Figure 31.
Distribution Analysis of %Y(1) Improved over Y(1')

A nderson-Darling N ormality Test
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Figure 31: Distribution of post-change performance shift values for ADT

6.3 Discussion
The analysis presented in this Chapter 6 demonstrates that the scheduling tactic
change was effective in reducing delays in the transitions of care between L&D and PP.
This conclusion corroborates with the conclusion in Chapter 5 that the scheduling tactic
change successfully reduced the Holds Rate in IP2 as compared to BL given the
definition of Holds Rate provided in Chapter 4, which validates both findings between
the MCS model and DES model. This observation confirms that this procedure can allow
similar conclusions to be reached using different methodologies to analyze the same
environment.
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CHAPTER 7
CONCLUSIONS

The objective of this dissertation is to provide a method for evaluating the
difference in performance after an organization makes a change while considering the
stochastic nature of the environment in which it operates. The literature review of
Chapter 2 identified that simulation is an effective approach to analyze systems with
stochastic variables and that organizations can be viewed as complex systems.
Furthermore, models discussed in literature have been used to evaluate potential system
designs and there does not appear to be use of simulation to evaluate current or past
performance or the effectiveness of a new system design that is already implemented.
The procedure proposed in Chapter 3 was developed as a means for meeting the objective
of this dissertation and it contributes an understanding of how simulation can be used to
analyze the performance of organizations as complex systems.

Specifically, this

dissertation work advances the ability to assess the impact a change has made on the
performance of an organization with a quantitative approach that uses simulation to
account for the influence of stochastic variables and uncontrolled parameters.
The validity of the procedure was demonstrated in Chapters 5 and 6 with the case
study introduced in Chapter 4. In Chapter 5, the scheduling tactic change of the case
study was assessed to be more effective than the observed performance shift of
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IP1 vs. BL based on the results of the procedure. The uncontrolled environment of the
mother-baby service line, which included nursing judgment on factors related to clinical
care and patient-family satisfaction, presented unfavorable influence on the Holds Rate in
the IP1 vs. BL comparison. Conversely, the procedure was used to show that this
uncontrolled environment provided favorable influence in the IP2 vs. BL comparison
since the scheduling tactic change was assessed to be less effective than the observed
performance shift of IP2 vs. BL indicated. However, the results of the procedure in both
comparisons led to the conclusion that the scheduling tactic change had a reducing effect
on the Holds Rate.
In Chapter 6, the analysis using the procedure demonstrated that the scheduling
tactic change was effective in reducing delays in the transitions of care between L&D and
PP. This conclusion indicated that convergent validity was achieved between the DES
models and MCS models in using the procedure since determining a patient to be held
involves judging the transition of care to be unintentionally delayed.
Regarding applicability of the procedure, Chapter 5 demonstrated that the
procedure can allow organizations to quantitatively assess the effectiveness of a change
while accounting for unfavorable or favorable influence from the uncontrolled
environment. In addition, Chapters 5 and 6 together showed that the procedure can be
used with different simulation methods to reach similar conclusions. Furthermore, the
case study demonstrated that using this procedure can enable leadership to better
understand the efficacy of a change, which can allow leaders to remain patient with a
change when uncontrolled conditions are unfavorable. In the case study, insights gained
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from use of the procedure promoted the key understanding leaders had of the project’s
success relative to the dynamics of its environment.
It is also possible that meeting the objective with this procedure may yield
additional advantages with risk taking and achievement.

Reeve (1997) stated that

situations involving the opportunity for achievement occur when a person knows that the
performance attributed to him or her will lead to an evaluation, favorable or unfavorable,
that may serve as the basis for assessing personal competency. Furthermore, Atkinson
(1957, 1964) asserted that achievement behaviors are guided by both a tendency to
approach success and a tendency to avoid failure. In this assertion, the perception of the
probability of success is paramount to taking a risk, aside from intrinsic motives and
extrinsic incentives associated with that risk. Also, Burger (1985) posited that one’s
desire to establish control influenced the degree of persistence with confronting a difficult
task (i.e., a situation that involves a lower probability of success). Thus, in complex
environments where organizations have limited control, the probability of success may be
perceived as being low, especially by decision-makers with low desire for control, and
this may lead to performance stagnation due to inaction. However, use of the proposed
procedure allows for performance to be assessed independent of uncontrollable
parameters and this form of assessment may favorably affect the perception decisionmakers have of the probability of success.

This benefit, along with an accurate

understanding of risk associated with a proposed change in deciding whether to
implement it, would serve to promote performance growth.
The case study presented in this dissertation applied the proposed procedure using
an MCS model and a DES model. As stated in Chapter 2, other simulation methods
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exist. Applying this procedure using other simulation models may advance research
related to the objective of this dissertation. For example, an ABS model may be used to
further understand how dynamic complexity in the broader environment affects
uncontrollable parameters of agents’ decision-making behaviors.
Another opportunity for future research is to study the impact of technology in
addressing Questions #1 and #2.

For instance, parameters once considered to be

uncontrollable may later be viewed as being controllable with the advent of new
technology. Also, the ability to measure and study more parameters may improve as new
means of data technology emerge.
While there may be other opportunities for future research in this topic, a final
proposal for research is to investigate other means of addressing Questions #1 and #2.
For example, the proposed procedure in Chapter 3 and the case study analyses of
Chapters 5 and 6 applied frequentist inference while an approach using Bayesian
inference could be explored.
Aside from further research, opportunities exist in the application of the proposed
procedure. As mentioned in Chapter 1, irrational reaction to observed performance can
take place when uncontrolled external forces overshadow the impact of the change being
assessed in either the form of the unfortunate loser condition or the undeserving winner
condition.

The ability of the proposed procedure to provide an assessment of

performance that isolates the impacts of these external forces can potentially enable an
organization to better understand the cause-and-effect relationships of its actions and
thereby leverage this knowledge to become more sustainable.
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